| 1 | 1- Deoxygalactonojirimycin | - | - | - | - | [1] 19 19 💬
|
| 2 | 1-deoxygalactonojirimycin hydrochloride | [1] Migalastat Migalastat | [2] Migalastat hydrochloride
Migalastat hydrochloride
,
Migalastat
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 3 | 12 lead electrocardiogram | - | - | - | - | [1] 19 19 💬
|
| 4 | 12S-IT | - | - | - | - | [1] 19 19 💬
|
| 5 | 15-0 H20 | - | - | - | - | [2] 6 6, 19 💬
|
| 6 | 1629063-78-0 | - | - | - | - | [1] 19 19 💬
|
| 7 | 2(S)-(ACETYLAMINO)-4-METHYLPENTANOIC ACID | - | - | - | - | [1] 19 19 💬
|
| 8 | 2-hour Holter Monitor | - | - | - | - | [1] 19 19 💬
|
| 9 | 4D-310 | [1] 4D-310 4D-310 | - | - | - | [1] 19 19 💬
|
| 10 | 500 0500 0 | - | - | - | - | [1] 19 19 💬
|
| 11 | 89 Zirconium Recombinant Human Alpha-N-Acetylglucosaminidase (rhNAGLU) (radiolabeled) | - | - | - | - | [1] 19 19 💬
|
| 12 | 89Zr-SBC-103 | - | - | - | - | [1] 19 19 💬
|
| 13 | [045251016] | - | - | - | - | [1] 19 19 💬
|
| 14 | [14C] AT1001 | - | - | - | - | [1] 19 19 💬
|
| 15 | [14C]-Genz-112638 | - | - | - | - | [1] 19 19 💬
|
| 16 | [A16AB04] | - | - | - | - | [1] 19 19 💬
|
| 17 | [AAV2/8.TBG.hARSB] | - | - | - | - | [1] 19 19 💬
|
| 18 | [ACT-434964] | - | - | - | - | [1] 19 19 💬
|
| 19 | [AT1001] | - | - | - | - | [1] 19 19 💬
|
| 20 | [difenidramina cloridrato] | - | - | - | - | [1] 19 19 💬
|
| 21 | [DNL310] | - | - | - | - | [1] 19 19 💬
|
| 22 | [FLT190] | [1] FLT190 FLT190 | - | - | - | [1] 19 19 💬
|
| 23 | [GZ402671] | - | - | - | - | [1] 19 19 💬
|
| 24 | [HGT-1410] | - | - | - | - | [1] 19 19 💬
|
| 25 | [JR-141] | - | - | - | - | [1] 19 19 💬
|
| 26 | [NA] | - | - | - | - | [34] 3 3, 6, 11, 13, 14, 19, 28, 35, 41, 46, 49, 50, 53, 57, 62, 63, 65, 75, 79, 85, 90, 96, 97, 98, 113, 127, 162, 195, 223, 229, 251, 294, 299, 302 💬
|
| 27 | [OTL-200] | - | - | - | - | [1] 19 19 💬
|
| 28 | [Paracetamolo] | - | - | - | - | [4] 14 14, 19, 300, 309 💬
|
| 29 | [Prednisone] | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [5] 19 19, 66, 90, 300, 303 💬
|
| 30 | [PRX-102] | - | - | - | - | [1] 19 19 💬
|
| 31 | [rhLAMAN] | [1] Velmanase alfa Velmanase alfa | [1] Velmanase alfa
Velmanase alfa
💬
| [1] MAN2B1 MAN2B1 💬
| [2] Lysosome biogenesis Lysosome biogenesis, Other glycan degradation 💬 | [1] 19 19 💬
|
| 32 | [SAR402671, GZ402671 o GZ/SAR402671] | - | - | - | - | [2] 19 19, 67 💬
|
| 33 | [SAR402671, GZ402671 or GZ / SAR402671] | - | - | - | - | [1] 19 19 💬
|
| 34 | [SHP611] | - | - | - | - | [1] 19 19 💬
|
| 35 | [ST-920] | - | - | - | - | [1] 19 19 💬
|
| 36 | A (migalastat) | [1] Migalastat Migalastat | [2] Migalastat hydrochloride
Migalastat hydrochloride
,
Migalastat
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 37 | A16AX06 | - | - | - | - | [1] 19 19 💬
|
| 38 | AAV2/8.TBG.hARSB | - | - | - | - | [1] 19 19 💬
|
| 39 | AAV2CUhCLN2 (3x10^12 particle units) | - | - | - | - | [1] 19 19 💬
|
| 40 | AAV9-CAG-coh-SGSH | - | - | - | - | [1] 19 19 💬
|
| 41 | AAV9-GLB1 | - | - | - | - | [1] 19 19 💬
|
| 42 | AAVrh.10-hMPSIIIA | - | - | - | - | [1] 19 19 💬
|
| 43 | AAVrh.10cuARSA | - | - | - | - | [1] 19 19 💬
|
| 44 | AAVrh.10CUCLN2 | - | - | - | - | [1] 19 19 💬
|
| 45 | AAVrh.10CUhCLN2 vector 2.85x10^11 genome copies | - | - | - | - | [1] 19 19 💬
|
| 46 | AAVrh.10CUhCLN2 vector 9.0x10^11 genome copies | - | - | - | - | [1] 19 19 💬
|
| 47 | Abatacept | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [28] 2 2, 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
|
| 48 | Abcertin | - | - | - | - | [1] 19 19 💬
|
| 49 | Abdominal ultrasound | - | - | - | - | [2] 19 19, 231 💬
|
| 50 | ABO-101 | - | - | - | - | [2] 19 19, 234 💬
|
| 51 | ABO-102 | [1] Rebisufligene etisparvovec Rebisufligene etisparvovec | - | - | - | [1] 19 19 💬
|
| 52 | Accupro | - | - | - | - | [1] 19 19 💬
|
| 53 | Accuretic | - | - | - | - | [1] 19 19 💬
|
| 54 | Acetaminophen | [1] Acetaminophen Acetaminophen | [1] Acetaminophen
Acetaminophen
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [19] 11 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
|
| 55 | Acetylcysteine | [1] Acetylcysteine Acetylcysteine | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [25] 2 2, 6, 13, 19, 20, 21, 34, 49, 51, 53, 58, 63, 85, 90, 94, 97, 111, 164, 193, 233, 296, 298, 299, 303, 337 💬
|
| 56 | Acetylcysteine amide | [2] Acetylcysteine Acetylcysteine, Acetylcysteine amide | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [3] 19 19, 90, 303 💬
|
| 57 | ACT-434964 | - | - | - | - | [1] 19 19 💬
|
| 58 | Active comparator (Agalsidase beta) | [1] Agalsidase beta Agalsidase beta | [1] Agalsidase beta
Agalsidase beta
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 59 | Adalimumab | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [22] 19 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
|
| 60 | Adalimumab Injection [Humira] | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 19 19 💬
|
| 61 | ADENO-ASSOCIATED VIRAL (AAV) SEROTYPE 8 (AAV2/8) VECTOR WITH LIVER-SPECIFIC THYROXINE-BINDING GLOBULIN (TBG) PROMOTER, DRIVING THE EXPRESSION OF THE HUMAN ARSB GENE | - | - | - | - | [1] 19 19 💬
|
| 62 | Adeno-associated viral vector serotype 9 containing the human N-acetyl-alpha-glucosaminidase gene | - | - | - | - | [1] 19 19 💬
|
| 63 | Adeno-associated virus (AAV) serotype rh.10 expressing human betagalactosidase (AAVrh.10-CAG-betagal) | - | - | - | - | [1] 19 19 💬
|
| 64 | Adeno-associated virus (AAV) serotype rh.10 expressing human betagalactosidase (AAVrh.10-CAG-ßgal) | - | - | - | - | [1] 19 19 💬
|
| 65 | Adeno-associated virus serotype 2/6 encoding human alpha-galactosidase A cDNA | - | - | - | - | [1] 19 19 💬
|
| 66 | Adeno-associated virus serotype 2/6 encoding Human Iduronate 2-sulfatase (hIDS) gene donor vector, SB-A6P-HNT Donor Vector | - | - | - | - | [1] 19 19 💬
|
| 67 | Adeno-associated virus serotype 2/6 encoding human iduronidase (hIDUA) gene donor vector, SB-A6P-HRL Donor Vector | - | - | - | - | [1] 19 19 💬
|
| 68 | Adeno-associated virus serotype 2/6 encoding Left side-zinc finger nuclease (ZFN1), SB-A6P-ZLEFT Vector | - | - | - | - | [1] 19 19 💬
|
| 69 | Adeno-associated virus serotype 2/6 encoding Right side-zinc finger nuclease (ZFN2), SB-A6P-ZRIGHT Vector | - | - | - | - | [1] 19 19 💬
|
| 70 | Adeno-associated virus serotype hu68 containing the human GALC gene | - | - | - | - | [1] 19 19 💬
|
| 71 | Adeno-associated virus serotype rh.10 expressing beta-galactosidase | - | - | - | - | [1] 19 19 💬
|
| 72 | Adjuvant IM Therapy | - | - | - | - | [1] 19 19 💬
|
| 73 | Adjuvant Immunomodulatory (IM) Therapy | - | - | - | - | [1] 19 19 💬
|
| 74 | Administration Kit | - | - | - | - | [1] 19 19 💬
|
| 75 | Adrabetadex | - | - | - | - | [1] 19 19 💬
|
| 76 | Afegostat | [1] Afegostat Afegostat | [2] Afegostat
Afegostat
,
Afegostat tartrate
💬
| - | - | [1] 19 19 💬
|
| 77 | Afegostat tartrate | [1] Afegostat Afegostat | [2] Afegostat
Afegostat
,
Afegostat tartrate
💬
| - | - | [1] 19 19 💬
|
| 78 | Agalsidase | - | - | - | - | [1] 19 19 💬
|
| 79 | AGALSIDASE ALFA | [1] Agalsidase alfa Agalsidase alfa | [1] Agalsidase alfa
Agalsidase alfa
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 80 | Agalsidase Alpha | - | - | - | - | [1] 19 19 💬
|
| 81 | AGALSIDASE BETA | [1] Agalsidase beta Agalsidase beta | [1] Agalsidase beta
Agalsidase beta
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 82 | AGALSIDASE BETA (GZ419828) | [1] Agalsidase beta Agalsidase beta | [1] Agalsidase beta
Agalsidase beta
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 83 | Agalsidase beta (recombinant form) | [1] Agalsidase beta Agalsidase beta | [1] Agalsidase beta
Agalsidase beta
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 84 | Agalsidase beta from Biosidus 1 mg/kg | [1] Agalsidase beta Agalsidase beta | [1] Agalsidase beta
Agalsidase beta
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 85 | AGALSIDASI ALFA | - | - | - | - | [1] 19 19 💬
|
| 86 | AGALSIDASI BETA | - | - | - | - | [1] 19 19 💬
|
| 87 | AGT-181 | - | - | - | - | [1] 19 19 💬
|
| 88 | AGT-181 (HIRMAb-IDUA) | - | - | - | - | [1] 19 19 💬
|
| 89 | AGT-182 | [1] AGT-182 AGT-182 | - | - | - | [1] 19 19 💬
|
| 90 | AL01211 | - | - | - | - | [2] 19 19, 67 💬
|
| 91 | Aldurazyme | - | - | - | - | [1] 19 19 💬
|
| 92 | Aldurazyme (laronidase) | [1] Laronidase Laronidase | [1] Laronidase
Laronidase
💬
| [1] IDUA IDUA 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [2] 19 19, 256 💬
|
| 93 | Aldurazyme (Recombinant Human Alpha-L-Iduronidase) | - | - | - | - | [1] 19 19 💬
|
| 94 | ALDURAZYME*INFUS 1FL 5ML 500U | - | - | - | - | [1] 19 19 💬
|
| 95 | Aldurazyme® | - | - | - | - | [1] 19 19 💬
|
| 96 | ALEMTUZUMAB | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬
| - | - | [21] 13 13, 14, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 107, 164, 283, 284, 285, 326 💬
|
| 97 | Alendronate sodium | [1] Alendronic acid Alendronic acid | [2] Alendronate sodium
Alendronate sodium
,
Alendronic acid
💬
| [1] FDPS FDPS 💬
| [3] Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | [4] 19 19, 46, 223, 299 💬
|
| 98 | Alfa-manosidadas humana recombinante | - | - | - | - | [1] 19 19 💬
|
| 99 | ALISERIN - 25 MG GRANULATO EFFERVESCENTE 20 BUSTINE | - | - | - | - | [1] 19 19 💬
|
| 100 | Allogeneic stem cell transplantation | - | - | - | - | [5] 19 19, 20, 49, 62, 84 💬
|
| 101 | Ambroxol | [1] Ambroxol Ambroxol | [2] Ambroxol hydrochloride
Ambroxol hydrochloride
,
Ambroxol
💬
| - | - | [3] 2 2, 6, 19 💬
|
| 102 | Ambroxol Hydrochloride | [1] Ambroxol Ambroxol | [2] Ambroxol hydrochloride
Ambroxol hydrochloride
,
Ambroxol
💬
| - | - | [2] 6 6, 19 💬
|
| 103 | Ambroxol Hydrochloride 30 mg tablet - 18 mg/kg/day | [1] Ambroxol Ambroxol | [2] Ambroxol hydrochloride
Ambroxol hydrochloride
,
Ambroxol
💬
| - | - | [1] 19 19 💬
|
| 104 | Ambroxol Hydrochloride 30 mg tablet - 27 mg/kg/day | [1] Ambroxol Ambroxol | [2] Ambroxol hydrochloride
Ambroxol hydrochloride
,
Ambroxol
💬
| - | - | [1] 19 19 💬
|
| 105 | Ambroxol Hydrochloride 30 mg tablet - 9 mg/kg/day | [1] Ambroxol Ambroxol | [2] Ambroxol hydrochloride
Ambroxol hydrochloride
,
Ambroxol
💬
| - | - | [1] 19 19 💬
|
| 106 | AMBROXOL HYDROCHLORIDE PH. EUR. | [1] Ambroxol Ambroxol | [2] Ambroxol hydrochloride
Ambroxol hydrochloride
,
Ambroxol
💬
| - | - | [1] 19 19 💬
|
| 107 | AMT-191 | - | - | - | - | [1] 19 19 💬
|
| 108 | Anakinra | [1] Anakinra Anakinra | [1] Anakinra
Anakinra
💬
| [2] IL1R1 IL1R1, IL1R2 💬
| [15] Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | [22] 2 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬
|
| 109 | Antihistamine | - | - | - | - | [3] 13 13, 19, 46 💬
|
| 110 | Antipyretic | - | - | - | - | [2] 19 19, 257 💬
|
| 111 | ARIMOCLOMOL | [1] Arimoclomol Arimoclomol | [2] Arimoclomol
Arimoclomol
,
Arimoclomol citrate
💬
| - | - | [3] 2 2, 15, 19 💬
|
| 112 | Arimoclomol (hard gelatine capsule) | [1] Arimoclomol Arimoclomol | [2] Arimoclomol
Arimoclomol
,
Arimoclomol citrate
💬
| - | - | [1] 19 19 💬
|
| 113 | Arimoclomol (HPMC capsule) | [1] Arimoclomol Arimoclomol | [2] Arimoclomol
Arimoclomol
,
Arimoclomol citrate
💬
| - | - | [1] 19 19 💬
|
| 114 | Arimoclomol citrate | [1] Arimoclomol Arimoclomol | [2] Arimoclomol
Arimoclomol
,
Arimoclomol citrate
💬
| - | - | [2] 15 15, 19 💬
|
| 115 | Arylsulfatase A | - | - | - | - | [1] 19 19 💬
|
| 116 | AT-GTX-501 | - | - | - | - | [1] 19 19 💬
|
| 117 | AT1001 | - | - | - | - | [1] 19 19 💬
|
| 118 | AT1001 150 mg | - | - | - | - | [1] 19 19 💬
|
| 119 | AT2101 | - | - | - | - | [1] 19 19 💬
|
| 120 | ATALUREN | [1] Ataluren Ataluren | [1] Ataluren
Ataluren
💬
| - | - | [6] 19 19, 113, 140, 246, 299, 329 💬
|
| 121 | ATG | - | - | - | - | [6] 13 13, 19, 60, 96, 222, 285 💬
|
| 122 | AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH A LENTIVIRAL VECTOR CONTAINING THE HUMAN SGSH GENE | - | - | - | - | [1] 19 19 💬
|
| 123 | Autologous CD34+ cells transduced with a lentiviral vector encoding the ARSA cDNA | - | - | - | - | [1] 19 19 💬
|
| 124 | Autologous Plasmablasts | - | - | - | - | [1] 19 19 💬
|
| 125 | Autologous Plasmablasts (B cells) | - | - | - | - | [1] 19 19 💬
|
| 126 | AVR-RD-01 | [1] AVR-RD-01 AVR-RD-01 | - | - | - | [1] 19 19 💬
|
| 127 | AVR-RD-02 | [1] AVR-RD-02 AVR-RD-02 | - | - | - | [1] 19 19 💬
|
| 128 | AX 250 | - | - | - | - | [1] 19 19 💬
|
| 129 | AXO-AAV-GM2 | - | - | - | - | [1] 19 19 💬
|
| 130 | AXO-AAV-GM2 High Dose | - | - | - | - | [1] 19 19 💬
|
| 131 | AXO-AAV-GM2 Low Dose | - | - | - | - | [1] 19 19 💬
|
| 132 | AXO-AAV-GM2 Middle Dose | - | - | - | - | [1] 19 19 💬
|
| 133 | AXO-AAV-GM2 Starting Dose | - | - | - | - | [1] 19 19 💬
|
| 134 | AZ-3102 | - | - | - | - | [1] 19 19 💬
|
| 135 | AZ-3102 (Dose 1) | - | - | - | - | [1] 19 19 💬
|
| 136 | AZ-3102 (Dose 2) | - | - | - | - | [1] 19 19 💬
|
| 137 | Azathioprine | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [26] 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 57, 63, 65, 66, 84, 85, 93, 94, 95, 96, 97, 162, 223, 300 💬
|
| 138 | Azathioprine (AZA) | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [5] 13 13, 19, 49, 55, 97 💬
|
| 139 | B (migalastat) | [1] Migalastat Migalastat | [2] Migalastat hydrochloride
Migalastat hydrochloride
,
Migalastat
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 140 | Barium | [1] Barium Barium | - | - | - | [5] 2 2, 6, 19, 97, 98 💬
|
| 141 | Behavioral: Neurocognitive testing | - | - | - | - | [1] 19 19 💬
|
| 142 | Behavioral: PICC or other Central line placement | - | - | - | - | [1] 19 19 💬
|
| 143 | Beta-mercaptoethylamine Hydrochloride & 2-aminoethanethiol Hydrochloride | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [1] 19 19 💬
|
| 144 | Biological assays | - | - | - | - | [1] 19 19 💬
|
| 145 | Blood draw | - | - | - | - | [16] 3 3, 6, 13, 19, 46, 48, 49, 51, 58, 65, 67, 193, 215, 231, 298, 299 💬
|
| 146 | Blood sample | - | - | - | - | [33] 2 2, 3, 6, 8, 10, 13, 14, 19, 34, 46, 48, 49, 51, 53, 61, 63, 65, 66, 67, 77, 79, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 299 💬
|
| 147 | Blood sampling for dosage | - | - | - | - | [1] 19 19 💬
|
| 148 | BM110 | - | - | - | - | [1] 19 19 💬
|
| 149 | BMN 110 | - | - | - | - | [1] 19 19 💬
|
| 150 | BMN 110 - Every Other Week | - | - | - | - | [1] 19 19 💬
|
| 151 | BMN 110 - Weekly | - | - | - | - | [1] 19 19 💬
|
| 152 | BMN 110 Every Other Week | - | - | - | - | [1] 19 19 💬
|
| 153 | BMN 110 Weekly | - | - | - | - | [1] 19 19 💬
|
| 154 | BMN 190 | - | - | - | - | [1] 19 19 💬
|
| 155 | BMN 250 | - | - | - | - | [1] 19 19 💬
|
| 156 | BMN190 recombinant human tripeptidyl peptidase-1 (rhTPP1) | - | - | - | - | [1] 19 19 💬
|
| 157 | Brain MRI/MRS/fMRI | - | - | - | - | [1] 19 19 💬
|
| 158 | Brineura | - | - | - | - | [1] 19 19 💬
|
| 159 | BUSILVEX | - | - | - | - | [4] 19 19, 36, 60, 65 💬
|
| 160 | BUSILVEX - 6 MG/ML - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO - 10 ML 8 FLACONCINI | - | - | - | - | [2] 19 19, 65 💬
|
| 161 | Busulfan | [1] Busulfan Busulfan | [1] Busulfan
Busulfan
💬
| - | - | [14] 19 19, 20, 28, 34, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326 💬
|
| 162 | Busulfan, Cyclophosphamide, Antithymocyte Globulin | [2] Busulfan Busulfan, Cyclophosphamide | [3] Busulfan
Busulfan
,
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 19 19, 20 💬
|
| 163 | Busulfan, Cyclophosphamide, ATG | [2] Busulfan Busulfan, Cyclophosphamide | [3] Busulfan
Busulfan
,
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 19 19 💬
|
| 164 | BUSULFANO | - | - | - | - | [1] 19 19 💬
|
| 165 | C (migalastat) | [1] Migalastat Migalastat | [2] Migalastat hydrochloride
Migalastat hydrochloride
,
Migalastat
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 166 | Calcium | [1] Calcium Calcium | - | - | - | [39] 2 2, 3, 6, 13, 15, 19, 46, 48, 49, 51, 53, 56, 62, 67, 68, 71, 74, 75, 79, 84, 90, 93, 94, 95, 96, 97, 156, 186, 214, 215, 222, 224, 235, 256, 265, 271, 274, 298, 299 💬
|
| 167 | Calcium carbonate | [2] Calcium Calcium, Calcium carbonate | [2] Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | [10] 13 13, 19, 46, 53, 71, 75, 96, 97, 235, 299 💬
|
| 168 | CALD HR-D (High-Risk, Regimen C) | - | - | - | - | [5] 19 19, 20, 125, 234, 326 💬
|
| 169 | CALD HR-D (High-Risk, Regimen D) | - | - | - | - | [5] 19 19, 20, 125, 234, 326 💬
|
| 170 | CALD SR-A (Standard-Risk, Regimen A) | - | - | - | - | [5] 19 19, 20, 125, 234, 326 💬
|
| 171 | CALD SR-B (Standard-Risk, Regimen B) | - | - | - | - | [5] 19 19, 20, 125, 234, 326 💬
|
| 172 | Campath-1H | - | - | - | - | [6] 19 19, 20, 60, 65, 234, 326 💬
|
| 173 | Cannabidiol | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [20] 6 6, 8, 13, 19, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬
|
| 174 | Cannabidiol oral solution (Epidyolex) | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [3] 19 19, 158, 206 💬
|
| 175 | Cannabis sativa L., folium cum flore | - | - | - | - | [1] 19 19 💬
|
| 176 | Capsaicin | [1] Capsaicin Capsaicin | [1] Capsaicin
Capsaicin
💬
| [1] TRPV1 TRPV1 💬
| [2] Inflammatory mediator regulation of TRP channels Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [5] 2 2, 6, 19, 86, 226 💬
|
| 177 | Cebsulfase alfa | - | - | - | - | [1] 19 19 💬
|
| 178 | Cellule CD34+ autologhe trasdotte con IDUA LV codificante per il cDNA dell'alfa-L-iduronidasi | - | - | - | - | [1] 19 19 💬
|
| 179 | Cerdelga | - | - | - | - | [1] 19 19 💬
|
| 180 | CEREDASE™ | - | - | - | - | [1] 19 19 💬
|
| 181 | CEREZYME | - | - | - | - | [1] 19 19 💬
|
| 182 | Cerezyme (imiglucerase for injection) | [1] Imiglucerase Imiglucerase | [2] Alglucerase
Alglucerase
,
Imiglucerase
💬
| [1] GBA1 GBA1 💬
| [4] Cornified envelope formation Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 183 | Cerezyme 400 Units Powder for concentrate for solution for infusion | - | - | - | - | [1] 19 19 💬
|
| 184 | Cerezyme 400 Units Powder for concentrate for solution for infusionPharmaceutical Form: Powder for concentrate for solution for infusionINN or Proposed INN: ImigluceraseCAS Number: 154248-97-2Concentration unit: U unit(s)Concentration type: equalConcentration number: 400-Pharmaceutical form of the placebo: Solution for infusionRoute of administration of the placebo: Intravenous use | - | - | - | - | [1] 19 19 💬
|
| 185 | Cerezyme 400 Unità Polvere per concentrato per soluzione per infusione | - | - | - | - | [1] 19 19 💬
|
| 186 | Cerezyme® | - | - | - | - | [1] 19 19 💬
|
| 187 | Cerezyme® / Imiglucerase | [1] Imiglucerase Imiglucerase | [2] Alglucerase
Alglucerase
,
Imiglucerase
💬
| [1] GBA1 GBA1 💬
| [4] Cornified envelope formation Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 188 | Cerliponase Alfa | [1] Cerliponase alfa Cerliponase alfa | [1] Cerliponase alfa
Cerliponase alfa
💬
| [1] TPP1 TPP1 💬
| [1] Lysosome biogenesis Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 189 | Cetirizine | [1] Cetirizine Cetirizine | [2] Cetirizine hydrochloride
Cetirizine hydrochloride
,
Cetirizine
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [3] 13 13, 19, 35 💬
|
| 190 | CHEMICALLY MODIFIED RECOMBINANT HUMAN SULFAMIDASE | - | - | - | - | [1] 19 19 💬
|
| 191 | CHF6657 | - | - | - | - | [1] 19 19 💬
|
| 192 | CHOLECALCIFEROL | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [10] 13 13, 19, 34, 46, 49, 96, 97, 222, 298, 299 💬
|
| 193 | Cholesterol | [1] Cholesterol Cholesterol | [1] Cholesterol
Cholesterol
💬
| - | - | [10] 8 8, 19, 71, 79, 90, 160, 222, 259, 261, 310 💬
|
| 194 | CliniMACS® TCR a/beta Reagent Kit and CliniMACS® CD19 System | - | - | - | - | [3] 19 19, 96, 222 💬
|
| 195 | CliniMACS® TCR a/ß Reagent Kit and CliniMACS® CD19 System | - | - | - | - | [3] 19 19, 96, 222 💬
|
| 196 | Clofarabine | [1] Clofarabine Clofarabine | [1] Clofarabine
Clofarabine
💬
| [3] POLA1 POLA1, POLA2, RRM1 💬
| [5] DNA replication DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [9] 19 19, 20, 40, 46, 49, 60, 96, 234, 326 💬
|
| 197 | Contrast sensitivity measurement | - | - | - | - | [1] 19 19 💬
|
| 198 | Coversyl | - | - | - | - | [2] 19 19, 167 💬
|
| 199 | Coversyl PLUS | - | - | - | - | [1] 19 19 💬
|
| 200 | CRYOPRESERVED AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH A LENTIVIRAL VECTOR CONTAINING HUMAN SGSH GENE | - | - | - | - | [1] 19 19 💬
|
| 201 | Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [50] 11 11, 13, 14, 16, 19, 20, 26, 28, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 62, 63, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 223, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
|
| 202 | Cyclophosphamide 100 mg/Kg | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 19 19, 222 💬
|
| 203 | Cyclophosphamide 1200 mg/Kg | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 19 19, 222 💬
|
| 204 | Cyclosporine | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [39] 11 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
|
| 205 | Cyclosporine A | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [12] 19 19, 20, 36, 49, 50, 53, 58, 60, 107, 228, 234, 283 💬
|
| 206 | Cyclosporine A (CsA) | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 19 19, 60 💬
|
| 207 | Cystadane anhydrous | - | - | - | - | [1] 19 19 💬
|
| 208 | CYSTADROPS | - | - | - | - | [1] 19 19 💬
|
| 209 | CYSTADROPS 0.55% eye drops, solution | - | - | - | - | [1] 19 19 💬
|
| 210 | CYSTAGON | - | - | - | - | [3] 8 8, 19, 299 💬
|
| 211 | Cystagon 150mg | - | - | - | - | [1] 19 19 💬
|
| 212 | Cystagon 50mg | - | - | - | - | [1] 19 19 💬
|
| 213 | Cystagon® | - | - | - | - | [1] 19 19 💬
|
| 214 | Cystagon® (Cysteamine Bitartrate) | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [1] 19 19 💬
|
| 215 | Cysteamine | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [4] 8 8, 19, 21, 299 💬
|
| 216 | Cysteamine (mercaptamine) viscous solution | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [1] 19 19 💬
|
| 217 | Cysteamine Bitartrate | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [4] 8 8, 19, 21, 299 💬
|
| 218 | Cysteamine bitartrate (INN: mercaptamine bitartrate | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [1] 19 19 💬
|
| 219 | Cysteamine bitartrate (INN: mercaptamine bitartrate ) | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [1] 19 19 💬
|
| 220 | Cysteamine bitartrate (INN: mercaptamine bitartrate) | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [1] 19 19 💬
|
| 221 | Cysteamine Bitartrate Delayed-release Capsules | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [1] 19 19 💬
|
| 222 | Cysteamine Bitartrate Delayed-release Capsules (RP103) | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [1] 19 19 💬
|
| 223 | CYSTEAMINE HYDROCHLORIDE | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [1] 19 19 💬
|
| 224 | Cysteine | [1] Cysteine Cysteine | [2] L-Cysteine
L-Cysteine
,
Cysteine hydrochloride
💬
| - | - | [13] 6 6, 13, 19, 34, 60, 84, 85, 88, 90, 254, 296, 310, 337 💬
|
| 225 | D (migalastat) | [1] Migalastat Migalastat | [2] Migalastat hydrochloride
Migalastat hydrochloride
,
Migalastat
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 226 | Dapagliflozin | [1] Dapagliflozin Dapagliflozin | [1] Dapagliflozin
Dapagliflozin
💬
| - | - | [16] 6 6, 19, 28, 40, 41, 49, 57, 66, 67, 86, 88, 97, 210, 215, 218, 222 💬
|
| 227 | Dapagliflozin 10mg Tab | [1] Dapagliflozin Dapagliflozin | [1] Dapagliflozin
Dapagliflozin
💬
| - | - | [4] 19 19, 97, 218, 222 💬
|
| 228 | DEFLEGMIN 75mg, kapsulki o przedluzonym uwalnianiu | - | - | - | - | [1] 19 19 💬
|
| 229 | DEXA scan | - | - | - | - | [3] 19 19, 46, 96 💬
|
| 230 | Dexamethasone | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [29] 13 13, 14, 16, 19, 28, 35, 46, 53, 63, 64, 65, 70, 71, 74, 75, 81, 84, 90, 96, 97, 162, 222, 223, 235, 257, 283, 296, 299, 331 💬
|
| 231 | Diagnostic Test: 1 hour ECG | - | - | - | - | [1] 19 19 💬
|
| 232 | Diagnostic Test: 24 hour pulse wave analysis | - | - | - | - | [1] 19 19 💬
|
| 233 | Diagnostic Test: 24-hour blood pressure measurement | - | - | - | - | [1] 19 19 💬
|
| 234 | Diagnostic Test: 68Ga-DOTATATE PET/MRI | [1] Dotatate Dotatate | - | - | - | [1] 19 19 💬
|
| 235 | Diagnostic Test: Ambulatory blood pressure monitoring | - | - | - | - | [1] 19 19 💬
|
| 236 | Diagnostic Test: Audiology assessment with ABR | - | - | - | - | [1] 19 19 💬
|
| 237 | Diagnostic Test: Biochemistry and immune phenotyping | - | - | - | - | [1] 19 19 💬
|
| 238 | Diagnostic Test: Blood sample collection | - | - | - | - | [2] 19 19, 20 💬
|
| 239 | Diagnostic Test: blood sampling (alpha-Galactosidase & LysoGb3) | - | - | - | - | [2] 19 19, 58 💬
|
| 240 | Diagnostic Test: Bone density scan (DEXA) | - | - | - | - | [1] 19 19 💬
|
| 241 | Diagnostic Test: Cardiac MRI, ECG/Holter and Blood Biomarkers | - | - | - | - | [1] 19 19 💬
|
| 242 | Diagnostic Test: Cardio MRI | - | - | - | - | [1] 19 19 💬
|
| 243 | Diagnostic Test: Cardiopulmonary exercise testing (CPET) | - | - | - | - | [1] 19 19 💬
|
| 244 | Diagnostic Test: dry blood test | - | - | - | - | [2] 19 19, 97 💬
|
| 245 | Diagnostic Test: Dynamic retinal vessel analysis (DVA) | - | - | - | - | [1] 19 19 💬
|
| 246 | Diagnostic Test: Echocardiogram | - | - | - | - | [2] 19 19, 86 💬
|
| 247 | Diagnostic Test: Echocardiography | - | - | - | - | [2] 19 19, 58 💬
|
| 248 | Diagnostic Test: Echocardiography at M24 | - | - | - | - | [1] 19 19 💬
|
| 249 | Diagnostic Test: Echocardiography at T0 | - | - | - | - | [1] 19 19 💬
|
| 250 | Diagnostic Test: Electrocardiogram (EKG) | - | - | - | - | [1] 19 19 💬
|
| 251 | Diagnostic Test: Exercise test | - | - | - | - | [1] 19 19 💬
|
| 252 | Diagnostic Test: Laboratory tests | - | - | - | - | [1] 19 19 💬
|
| 253 | Diagnostic Test: Measures of arterial stiffness and endothelial function | - | - | - | - | [1] 19 19 💬
|
| 254 | Diagnostic Test: Ophthalmological consultation | - | - | - | - | [1] 19 19 💬
|
| 255 | Diagnostic Test: Optical coherence tomography (OCT) | - | - | - | - | [1] 19 19 💬
|
| 256 | Diagnostic Test: Questionnaires (Patient reported outcomes) | - | - | - | - | [1] 19 19 💬
|
| 257 | Diagnostic Test: Serum and urine biomarkers | - | - | - | - | [1] 19 19 💬
|
| 258 | Diagnostic Test: Static retinal vessel analysis (SVA) | - | - | - | - | [1] 19 19 💬
|
| 259 | DIFENIDRAMINA CLORIDRATO | - | - | - | - | [3] 11 11, 19, 63 💬
|
| 260 | Diphenhydramine | [1] Diphenhydramine Diphenhydramine | [4] Diphenhydramine
Diphenhydramine
,
Diphenhydramine hydrochloride
,
Diphenhydramine salicylate
,
Diphenhydramine citrate
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [12] 11 11, 13, 19, 49, 51, 63, 70, 86, 96, 222, 256, 300 💬
|
| 261 | DNL126 | - | - | - | - | [1] 19 19 💬
|
| 262 | DNL310 | - | - | - | - | [1] 19 19 💬
|
| 263 | DNL310 Drug Substance | - | - | - | - | [1] 19 19 💬
|
| 264 | Dotatate | [1] Dotatate Dotatate | - | - | - | [5] 19 19, 41, 75, 84, 238 💬
|
| 265 | Dried blood spot (DBS) sampling | - | - | - | - | [1] 19 19 💬
|
| 266 | DRX005B | - | - | - | - | [1] 19 19 💬
|
| 267 | DUOC-01 | - | - | - | - | [3] 13 13, 19, 20 💬
|
| 268 | E (migalastat) | [1] Migalastat Migalastat | [2] Migalastat hydrochloride
Migalastat hydrochloride
,
Migalastat
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 269 | Echocardiogram | - | - | - | - | [3] 19 19, 215, 216 💬
|
| 270 | ELAPRASE | - | - | - | - | [1] 19 19 💬
|
| 271 | Elaprase 2mg/ml | - | - | - | - | [1] 19 19 💬
|
| 272 | Elaprase for intravenous (IV) infusion | - | - | - | - | [1] 19 19 💬
|
| 273 | Elaprase_0.5mg/kg | - | - | - | - | [1] 19 19 💬
|
| 274 | Elelyso | - | - | - | - | [1] 19 19 💬
|
| 275 | Elelyso 60 units/kg | - | - | - | - | [1] 19 19 💬
|
| 276 | Elfabrio | - | - | - | - | [1] 19 19 💬
|
| 277 | Eliglustat | [1] Eliglustat Eliglustat | [2] Eliglustat
Eliglustat
,
Eliglustat tartrate
💬
| [1] UGCG UGCG 💬
| [2] Cornified envelope formation Cornified envelope formation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 278 | Eliglustat GZ385660 | [1] Eliglustat Eliglustat | [2] Eliglustat
Eliglustat
,
Eliglustat tartrate
💬
| [1] UGCG UGCG 💬
| [2] Cornified envelope formation Cornified envelope formation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 279 | ELIGLUSTAT TARTRATE | [1] Eliglustat Eliglustat | [2] Eliglustat
Eliglustat
,
Eliglustat tartrate
💬
| [1] UGCG UGCG 💬
| [2] Cornified envelope formation Cornified envelope formation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 280 | Eliglustat Tartrate Capsules | [1] Eliglustat Eliglustat | [2] Eliglustat
Eliglustat
,
Eliglustat tartrate
💬
| [1] UGCG UGCG 💬
| [2] Cornified envelope formation Cornified envelope formation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 281 | Eliglustat Tartrate – Powder for Oral Suspension | [1] Eliglustat Eliglustat | [2] Eliglustat
Eliglustat
,
Eliglustat tartrate
💬
| [1] UGCG UGCG 💬
| [2] Cornified envelope formation Cornified envelope formation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 282 | Elosulfase alfa | [1] Elosulfase alfa Elosulfase alfa | [1] Elosulfase alfa
Elosulfase alfa
💬
| [1] GALNS GALNS 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 283 | Elosulfase Alfa 1 MG/ML Intravenous Solution [VIMIZIM] | [1] Elosulfase alfa Elosulfase alfa | [1] Elosulfase alfa
Elosulfase alfa
💬
| [1] GALNS GALNS 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 284 | ELX-02 | [1] ELX-02 ELX-02 | - | - | - | [3] 19 19, 218, 299 💬
|
| 285 | Enalapril | [1] Enalapril Enalapril | [2] Enalapril maleate
Enalapril maleate
,
Enalapril
💬
| [1] ACE ACE 💬
| [6] Chagas disease Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [10] 13 13, 19, 46, 57, 66, 113, 210, 222, 223, 279 💬
|
| 286 | Enalapril and other angiotensin converting enzyme inhibitors | [1] Enalapril Enalapril | [2] Enalapril maleate
Enalapril maleate
,
Enalapril
💬
| [1] ACE ACE 💬
| [6] Chagas disease Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [1] 19 19 💬
|
| 287 | Enriched Hematopoetic Stem Cell Infusion | - | - | - | - | [2] 19 19, 284 💬
|
| 288 | Enzyme replacement | - | - | - | - | [1] 19 19 💬
|
| 289 | Enzyme Replacement Agent | - | - | - | - | [2] 19 19, 256 💬
|
| 290 | Enzyme replacement therapy | - | - | - | - | [1] 19 19 💬
|
| 291 | Enzyme replacement therapy (Agalsidase alpha (Replagal®)) | - | - | - | - | [1] 19 19 💬
|
| 292 | Enzyme replacement therapy (ERT) | - | - | - | - | [1] 19 19 💬
|
| 293 | Epidiolex | - | - | - | - | [1] 19 19 💬
|
| 294 | ERT | - | - | - | - | [1] 19 19 💬
|
| 295 | EU-sourced Cerezyme | - | - | - | - | [1] 19 19 💬
|
| 296 | EXG110 Injection | - | - | - | - | [1] 19 19 💬
|
| 297 | Fabagal® (Agalsidase beta) | [1] Agalsidase beta Agalsidase beta | [1] Agalsidase beta
Agalsidase beta
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 298 | FABRAZYME | - | - | - | - | [1] 19 19 💬
|
| 299 | Fabrazyme (agalsidase beta) | [1] Agalsidase beta Agalsidase beta | [1] Agalsidase beta
Agalsidase beta
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 300 | Fabrazyme (agalsidase beta) 1 mg/kg | [1] Agalsidase beta Agalsidase beta | [1] Agalsidase beta
Agalsidase beta
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 301 | FABRAZYME - 35 MG POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE ENDOVENOSA 1 FLACONCINO | - | - | - | - | [1] 19 19 💬
|
| 302 | Fabrazyme 35 mg | - | - | - | - | [1] 19 19 💬
|
| 303 | Fabrazyme 5 mg | - | - | - | - | [1] 19 19 💬
|
| 304 | FBX-101 | [1] FBX-101 FBX-101 | - | - | - | [1] 19 19 💬
|
| 305 | Fexofenadine | [1] Fexofenadine Fexofenadine | [2] Fexofenadine hydrochloride
Fexofenadine hydrochloride
,
Fexofenadine
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [4] 6 6, 13, 19, 46 💬
|
| 306 | FLT190 | [1] FLT190 FLT190 | - | - | - | [1] 19 19 💬
|
| 307 | FLT201 | [1] FLT201 FLT201 | - | - | - | [1] 19 19 💬
|
| 308 | FLUDARABINA ACCORD - 25 MG/ML CONCENTRATO PER SOLUZIONE INIETTABILE O PER INFUSIONE 5 FLACONCINI IN VETRO DA 2 ML | - | - | - | - | [1] 19 19 💬
|
| 309 | FLUDARABINA FOSFATO | - | - | - | - | [1] 19 19 💬
|
| 310 | Fludarabine | [1] Fludarabine Fludarabine | [2] Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [30] 11 11, 13, 14, 16, 19, 28, 34, 35, 36, 44, 46, 49, 50, 51, 60, 61, 62, 63, 65, 85, 96, 107, 164, 222, 223, 283, 284, 285, 286, 326 💬
|
| 311 | Fluorescein | [1] Fluorescein Fluorescein | [2] Fluorescein
Fluorescein
,
Fluorescein sodium
💬
| - | - | [4] 19 19, 22, 41, 97 💬
|
| 312 | GA-GCB | [1] Velaglucerase alfa Velaglucerase alfa | [1] Velaglucerase alfa
Velaglucerase alfa
💬
| [1] GBA1 GBA1 💬
| [4] Cornified envelope formation Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 313 | GA-GCB (velaglucerase alfa) | [1] Velaglucerase alfa Velaglucerase alfa | [1] Velaglucerase alfa
Velaglucerase alfa
💬
| [1] GBA1 GBA1 💬
| [4] Cornified envelope formation Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 314 | GABAPENTIN | [1] Gabapentin Gabapentin | [1] Gabapentin
Gabapentin
💬
| [5] CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬
| [10] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | [7] 6 6, 13, 18, 19, 70, 226, 298 💬
|
| 315 | Galafold | - | - | - | - | [1] 19 19 💬
|
| 316 | GALSULFASE | [1] Galsulfase Galsulfase | [1] Galsulfase
Galsulfase
💬
| [1] ARSB ARSB 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 317 | GC1111_0.5mg/kg | - | - | - | - | [1] 19 19 💬
|
| 318 | GC1111_1.0mg/kg | - | - | - | - | [1] 19 19 💬
|
| 319 | GC1119 | - | - | - | - | [1] 19 19 💬
|
| 320 | GC1123 | - | - | - | - | [1] 19 19 💬
|
| 321 | GC1130A | - | - | - | - | [1] 19 19 💬
|
| 322 | Gene Activated a-Galactosidase A | - | - | - | - | [1] 19 19 💬
|
| 323 | Gene Activated Human Glucocerebrosidase | - | - | - | - | [1] 19 19 💬
|
| 324 | Gene activated human glucocerebrosidase, velaglucerase alfa | [1] Velaglucerase alfa Velaglucerase alfa | [1] Velaglucerase alfa
Velaglucerase alfa
💬
| [1] GBA1 GBA1 💬
| [4] Cornified envelope formation Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 325 | Gene therapy | - | - | - | - | [2] 6 6, 19 💬
|
| 326 | Gene Transfer with an AAV9 Vector Expressing Human beta-galactosidase | - | - | - | - | [1] 19 19 💬
|
| 327 | Gene Transfer with an AAV9 Vector Expressing Human ß-galactosidase | - | - | - | - | [1] 19 19 💬
|
| 328 | Gene-Activated Human Glucocerebrosidase | - | - | - | - | [1] 19 19 💬
|
| 329 | Gene-Activated Human Glucocerebrosidase 200U/vial | - | - | - | - | [1] 19 19 💬
|
| 330 | Gene-Activated Human Glucocerebrosidase 400U/vial | - | - | - | - | [1] 19 19 💬
|
| 331 | Genetic HMI-203 | [1] HMI-203 HMI-203 | - | - | - | [1] 19 19 💬
|
| 332 | Genetic: 26 common Fabry mutation types in Taiwan | - | - | - | - | [1] 19 19 💬
|
| 333 | Genetic: Active Comparator: Allo-HSCT | - | - | - | - | [1] 19 19 💬
|
| 334 | Genetic: AT-GTX-501 | - | - | - | - | [1] 19 19 💬
|
| 335 | Genetic: Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII | - | - | - | - | [1] 19 19 💬
|
| 336 | Genetic: BBM-F101 injection | - | - | - | - | [1] 19 19 💬
|
| 337 | Genetic: Blood sampling for biological and genetic analysis | - | - | - | - | [1] 19 19 💬
|
| 338 | Genetic: CTNS-RD-04 or CTNS-RD-04-LB (where the suffix -LB stands for LentiBOOST) | - | - | - | - | [1] 19 19 💬
|
| 339 | Genetic: DFT383 | - | - | - | - | [1] 19 19 💬
|
| 340 | Genetic: Diagnosis of Fabry disease | - | - | - | - | [1] 19 19 💬
|
| 341 | Genetic: EXG110 injection | - | - | - | - | [1] 19 19 💬
|
| 342 | Genetic: Experimental: OTL-203 | [1] OTL-203 OTL-203 | - | - | - | [1] 19 19 💬
|
| 343 | Genetic: FLT190 | [1] FLT190 FLT190 | - | - | - | [1] 19 19 💬
|
| 344 | Genetic: FLT201 | [1] FLT201 FLT201 | - | - | - | [1] 19 19 💬
|
| 345 | Genetic: Frozen autologous CD34+ hematopoietic stem and progenitor cells genetically modified with the lentiviral vector IDUA LV, encoding for the a-L-iduronidase cDNA, in their final formulation medium. | - | - | - | - | [1] 19 19 💬
|
| 346 | Genetic: genetic analyses | - | - | - | - | [1] 19 19 💬
|
| 347 | Genetic: GLA gene | - | - | - | - | [1] 19 19 💬
|
| 348 | Genetic: High dose CLN-301 | - | - | - | - | [1] 19 19 💬
|
| 349 | Genetic: human glucocerebrosidase cDNA | - | - | - | - | [1] 19 19 💬
|
| 350 | Genetic: human glucocerebrosidase gene into autologous peripheral blood stem cells | - | - | - | - | [1] 19 19 💬
|
| 351 | Genetic: intracerebral administration of AAVrh.10cuARSA | - | - | - | - | [1] 19 19 💬
|
| 352 | Genetic: Intrathecal and intravenous LV gene therapy | - | - | - | - | [2] 19 19, 20 💬
|
| 353 | Genetic: JWK008 Single intravenous infusion administration | - | - | - | - | [1] 19 19 💬
|
| 354 | Genetic: Lentiviral TYF-ARSA correction of patient's autologous HSCs | - | - | - | - | [1] 19 19 💬
|
| 355 | Genetic: Low dose CLN-301 | - | - | - | - | [1] 19 19 💬
|
| 356 | Genetic: LY-M001 | - | - | - | - | [1] 19 19 💬
|
| 357 | Genetic: LY3884961 | [1] LY3884961 LY3884961 | - | - | - | [1] 19 19 💬
|
| 358 | Genetic: lymphocyte gene therapy | - | - | - | - | [1] 19 19 💬
|
| 359 | Genetic: LYS-GM101 | - | - | - | - | [1] 19 19 💬
|
| 360 | Genetic: NGN-101 | [1] NGN-101 NGN-101 | - | - | - | [1] 19 19 💬
|
| 361 | Genetic: No Intervention | - | - | - | - | [2] 19 19, 113 💬
|
| 362 | Genetic: OTL-200 | - | - | - | - | [1] 19 19 💬
|
| 363 | Genetic: OTL-200 Gene Therapy | - | - | - | - | [1] 19 19 💬
|
| 364 | Genetic: RGX-111 | [1] RGX-111 RGX-111 | - | - | - | [1] 19 19 💬
|
| 365 | Genetic: RGX-121 | [1] RGX-121 RGX-121 | - | - | - | [1] 19 19 💬
|
| 366 | Genetic: RGX-121-3102 | [1] RGX-121 RGX-121 | - | - | - | [1] 19 19 💬
|
| 367 | Genetic: SAF-301 | - | - | - | - | [1] 19 19 💬
|
| 368 | Genetic: scAAV9/AGA | - | - | - | - | [1] 19 19 💬
|
| 369 | Genetic: transduced CD34+ hematopoietic stem cell | - | - | - | - | [2] 19 19, 20 💬
|
| 370 | Genetic: TTX-381 | - | - | - | - | [1] 19 19 💬
|
| 371 | GENISTEIN | [1] Genistein Genistein | [1] Genistein
Genistein
💬
| - | - | [2] 19 19, 299 💬
|
| 372 | Genistein aglycone | [1] Genistein Genistein | [1] Genistein
Genistein
💬
| - | - | [1] 19 19 💬
|
| 373 | Genz-112638 | - | - | - | - | [1] 19 19 💬
|
| 374 | Genz-682452-AA | - | - | - | - | [1] 19 19 💬
|
| 375 | Genz-682452-AU | - | - | - | - | [3] 6 6, 19, 67 💬
|
| 376 | GLUCOCEREBROSIDASE | - | - | - | - | [1] 19 19 💬
|
| 377 | GLUCOCEREBROSIDASE UMANO GENE-ATTIVATO | - | - | - | - | [1] 19 19 💬
|
| 378 | GNR-055 | - | - | - | - | [1] 19 19 💬
|
| 379 | GNR-055 1.0-2.0-3.0 mg/kg | - | - | - | - | [1] 19 19 💬
|
| 380 | GNR-055 2.0 mg/kg | - | - | - | - | [1] 19 19 💬
|
| 381 | GNR-055 3.0 mg/kg | - | - | - | - | [1] 19 19 💬
|
| 382 | Gold | [1] Gold Gold | - | - | - | [71] 2 2, 5, 6, 11, 13, 17, 19, 21, 22, 28, 34, 35, 46, 49, 50, 53, 54, 56, 57, 58, 60, 63, 64, 65, 66, 68, 71, 75, 76, 77, 79, 84, 85, 86, 88, 91, 93, 95, 96, 97, 98, 107, 113, 127, 137, 158, 162, 167, 171, 193, 206, 215, 218, 222, 223, 224, 226, 227, 228, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318, 331, 340 💬
|
| 383 | GR181413 | - | - | - | - | [1] 19 19 💬
|
| 384 | GR181413A | - | - | - | - | [1] 19 19 💬
|
| 385 | GR181413A/AT1001 capsule | - | - | - | - | [1] 19 19 💬
|
| 386 | GR181413A/AT1001 solution | - | - | - | - | [1] 19 19 💬
|
| 387 | Growth Hormone | - | - | - | - | [10] 19 19, 46, 78, 96, 97, 107, 191, 193, 265, 299 💬
|
| 388 | GSK2788723 | - | - | - | - | [1] 19 19 💬
|
| 389 | GZ/SAR402671 | - | - | - | - | [2] 19 19, 67 💬
|
| 390 | GZ385660 | - | - | - | - | [1] 19 19 💬
|
| 391 | GZ402665 | - | - | - | - | [1] 19 19 💬
|
| 392 | GZ402671 | - | - | - | - | [1] 19 19 💬
|
| 393 | GZ402671 / SAR402671 | - | - | - | - | [1] 19 19 💬
|
| 394 | Hematopoetic Stem Cell Transplantation | - | - | - | - | [6] 19 19, 65, 121, 160, 308, 326 💬
|
| 395 | Hematopoietic stem cell infusion | - | - | - | - | [2] 19 19, 20 💬
|
| 396 | Hematopoietic Stem Cell Transplantation | - | - | - | - | [13] 11 11, 13, 14, 19, 20, 35, 46, 49, 51, 65, 96, 234, 285 💬
|
| 397 | Heparán N sulfatasa humana recombinante | - | - | - | - | [1] 19 19 💬
|
| 398 | Heparán N sulfatasa humana recombinante (rhHNS) | - | - | - | - | [1] 19 19 💬
|
| 399 | HGT-1110 | - | - | - | - | [1] 19 19 💬
|
| 400 | HGT-1111 | - | - | - | - | [1] 19 19 💬
|
| 401 | HGT-1410 | - | - | - | - | [1] 19 19 💬
|
| 402 | HGT-2310 | - | - | - | - | [1] 19 19 💬
|
| 403 | HIDS DONOR | - | - | - | - | [1] 19 19 💬
|
| 404 | HM15421/GC1134A | - | - | - | - | [1] 19 19 💬
|
| 405 | HMI-203 | [1] HMI-203 HMI-203 | - | - | - | [1] 19 19 💬
|
| 406 | HuCNS-SC | - | - | - | - | [1] 19 19 💬
|
| 407 | Human Glucocerebrosidase (prGCD) | - | - | - | - | [1] 19 19 💬
|
| 408 | Human N-sulfoglucosamine sulfohydrolase fused to a humanised monoclonal antibody targeting human transferrin receptor | - | - | - | - | [1] 19 19 💬
|
| 409 | Human Placental Derived Stem Cell | - | - | - | - | [4] 19 19, 20, 60, 284 💬
|
| 410 | Hunterase | - | - | - | - | [1] 19 19 💬
|
| 411 | Hydroxypropyl-beta-cyclodextrin | - | - | - | - | [1] 19 19 💬
|
| 412 | Hydroxypropyl-ß-cyclodextrin | - | - | - | - | [1] 19 19 💬
|
| 413 | Hydroxyurea | [1] Hydroxyurea Hydroxyurea | [1] Hydroxyurea
Hydroxyurea
💬
| [1] RRM2 RRM2 💬
| [5] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 💬 | [10] 3 3, 13, 19, 20, 46, 65, 85, 86, 107, 284 💬
|
| 414 | I2S | - | - | - | - | [1] 19 19 💬
|
| 415 | I2S-IT | - | - | - | - | [1] 19 19 💬
|
| 416 | IB1001 | - | - | - | - | [2] 19 19, 65 💬
|
| 417 | Iduronate-2-sulfatase enzyme replacement therapy | - | - | - | - | [1] 19 19 💬
|
| 418 | IDURONATE-2-SULFATASE FUSED TO A FC POLYPEPTIDE THAT BINDS TO THE HUMAN TRANSFERRIN RECEPTOR | - | - | - | - | [1] 19 19 💬
|
| 419 | IDURSULFASA | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬
| [1] IDS IDS 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 420 | IDURSULFASE | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬
| [1] IDS IDS 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 421 | Idursulfase (ELAPRASE) | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬
| [1] IDS IDS 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 422 | Idursulfase (I2S) | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬
| [1] IDS IDS 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 423 | Idursulfase (I2S)-IT | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬
| [1] IDS IDS 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 424 | Idursulfase beta | [2] Idursulfase Idursulfase, Idursulfase beta | [2] Idursulfase
Idursulfase
,
Idursulfase beta
💬
| [1] IDS IDS 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 425 | Idursulfase IT (1 mg) | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬
| [1] IDS IDS 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 426 | Idursulfase IT (10 mg) | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬
| [1] IDS IDS 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 427 | Idursulfase IT (30 mg) | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬
| [1] IDS IDS 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 428 | Idursulfase(12S)-IT | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬
| [1] IDS IDS 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 429 | Idursulfase(I2S)-IT | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬
| [1] IDS IDS 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 430 | Idursulfase-IT | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬
| [1] IDS IDS 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 431 | IDURSULFASI | - | - | - | - | [1] 19 19 💬
|
| 432 | IMD Preparative Regimen | - | - | - | - | [5] 19 19, 20, 125, 234, 326 💬
|
| 433 | IMIGLUCERASA | - | - | - | - | [1] 19 19 💬
|
| 434 | IMIGLUCERASE | [1] Imiglucerase Imiglucerase | [2] Alglucerase
Alglucerase
,
Imiglucerase
💬
| [1] GBA1 GBA1 💬
| [4] Cornified envelope formation Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 435 | Imiglucerase GZ437843 | [1] Imiglucerase Imiglucerase | [2] Alglucerase
Alglucerase
,
Imiglucerase
💬
| [1] GBA1 GBA1 💬
| [4] Cornified envelope formation Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 436 | IMIGLUCERASI | - | - | - | - | [1] 19 19 💬
|
| 437 | Imiglucérase (drug) pharmacokinetics | - | - | - | - | [1] 19 19 💬
|
| 438 | Inactive Reminder Capsules | - | - | - | - | [1] 19 19 💬
|
| 439 | Inactive Reminder Product | - | - | - | - | [1] 19 19 💬
|
| 440 | INN Not available | - | - | - | - | [2] 19 19, 46 💬
|
| 441 | INNOZIDE | - | - | - | - | [1] 19 19 💬
|
| 442 | Intrathecal recombinant human alpha iduronidase | - | - | - | - | [1] 19 19 💬
|
| 443 | Intravenous immunoglobulin (IVIg) | - | - | - | - | [8] 14 14, 17, 19, 63, 65, 85, 164, 296 💬
|
| 444 | Intraventricular Access Device | - | - | - | - | [1] 19 19 💬
|
| 445 | Iohexol | [1] Iohexol Iohexol | [1] Iohexol
Iohexol
💬
| - | - | [2] 19 19, 67 💬
|
| 446 | IRT Laronidase | [1] Laronidase Laronidase | [1] Laronidase
Laronidase
💬
| [1] IDUA IDUA 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 447 | Isaralgagene civaparvovec | [1] Isaralgagene civaparvovec Isaralgagene civaparvovec | - | - | - | [1] 19 19 💬
|
| 448 | Isofagamine tartrate | - | - | - | - | [1] 19 19 💬
|
| 449 | ISU302 | - | - | - | - | [1] 19 19 💬
|
| 450 | IV migalastat HCl | [1] Migalastat Migalastat | [2] Migalastat hydrochloride
Migalastat hydrochloride
,
Migalastat
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 451 | IVA 336 | - | - | - | - | [1] 19 19 💬
|
| 452 | IZCARGO | - | - | - | - | [1] 19 19 💬
|
| 453 | JR-141 | - | - | - | - | [1] 19 19 💬
|
| 454 | JR-141 or Idursulfase | [1] Idursulfase Idursulfase | [1] Idursulfase
Idursulfase
💬
| [1] IDS IDS 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 455 | JR-171 | - | - | - | - | [1] 19 19 💬
|
| 456 | JR-171 (lepunafusp alfa) | [1] Lepunafusp alfa Lepunafusp alfa | - | - | - | [1] 19 19 💬
|
| 457 | JR-441 | - | - | - | - | [1] 19 19 💬
|
| 458 | JR-446 | - | - | - | - | [1] 19 19 💬
|
| 459 | KANUMA | - | - | - | - | [1] 19 19 💬
|
| 460 | Kidney Transplant | - | - | - | - | [2] 19 19, 222 💬
|
| 461 | LAMAZYM | [1] Velmanase alfa Velmanase alfa | [1] Velmanase alfa
Velmanase alfa
💬
| [1] MAN2B1 MAN2B1 💬
| [2] Lysosome biogenesis Lysosome biogenesis, Other glycan degradation 💬 | [1] 19 19 💬
|
| 462 | LARONIDASE | [1] Laronidase Laronidase | [1] Laronidase
Laronidase
💬
| [1] IDUA IDUA 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [2] 19 19, 256 💬
|
| 463 | Laronidase ERT | [1] Laronidase Laronidase | [1] Laronidase
Laronidase
💬
| [1] IDUA IDUA 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 464 | Laronidase therapy and a stem cell transplant | [1] Laronidase Laronidase | [1] Laronidase
Laronidase
💬
| [1] IDUA IDUA 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 465 | Ledipasvir | [1] Ledipasvir Ledipasvir | [1] Ledipasvir
Ledipasvir
💬
| - | - | [1] 19 19 💬
|
| 466 | Ledipasvir/Sofosbuvir | [2] Ledipasvir Ledipasvir, Sofosbuvir | [2] Sofosbuvir
Sofosbuvir
,
Ledipasvir
💬
| - | - | [1] 19 19 💬
|
| 467 | Lenograstim | [1] Lenograstim Lenograstim | [1] Lenograstim
Lenograstim
💬
| [1] CSF3R CSF3R 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [8] 2 2, 13, 16, 18, 19, 57, 65, 97 💬
|
| 468 | Lentivirus Alpha-gal A transduced stem cells | - | - | - | - | [1] 19 19 💬
|
| 469 | Lepunafusp alfa | [1] Lepunafusp alfa Lepunafusp alfa | - | - | - | [1] 19 19 💬
|
| 470 | Leucine | [1] Leucine Leucine | [1] Leucine
Leucine
💬
| - | - | [13] 5 5, 6, 7, 18, 19, 65, 96, 97, 127, 280, 283, 284, 299 💬
|
| 471 | Leucovorin | [1] Leucovorin Leucovorin | [3] Leucovorin calcium
Leucovorin calcium
,
Folinic acid
,
Folinic acid calcium salt pentahydrate
💬
| - | - | [3] 13 13, 19, 46 💬
|
| 472 | Lipasa ácida lisosómica, esterasa, colesterol (gen humano LIPA), lipasa ácida lisosómica (gen humano LIPA) | - | - | - | - | [1] 19 19 💬
|
| 473 | Lisinopril | [1] Lisinopril Lisinopril | [2] Lisinopril
Lisinopril
,
Lisinopril
💬
| [1] ACE ACE 💬
| [6] Chagas disease Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [9] 19 19, 46, 49, 57, 66, 67, 113, 222, 223 💬
|
| 474 | Lopace | - | - | - | - | [1] 19 19 💬
|
| 475 | Loratadine | [1] Loratadine Loratadine | [1] Loratadine
Loratadine
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [5] 13 13, 19, 46, 89, 98 💬
|
| 476 | Losartan | [1] Losartan Losartan | [2] Losartan potassium
Losartan potassium
,
Losartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [20] 17 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
|
| 477 | Losartan and other angiotensin receptor blockers | [1] Losartan Losartan | [2] Losartan potassium
Losartan potassium
,
Losartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 19 19 💬
|
| 478 | Lucerastat | [1] Lucerastat Lucerastat | [1] Lucerastat
Lucerastat
💬
| [1] UGCG UGCG 💬
| [2] Cornified envelope formation Cornified envelope formation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 479 | Lumbar puncture | - | - | - | - | [9] 2 2, 6, 13, 14, 19, 96, 97, 127, 201 💬
|
| 480 | LY-M001 Injection | - | - | - | - | [1] 19 19 💬
|
| 481 | LY3884961 | [1] LY3884961 LY3884961 | - | - | - | [2] 6 6, 19 💬
|
| 482 | LYS-GM101 | - | - | - | - | [1] 19 19 💬
|
| 483 | LYS-SAF302 | [1] Olenasufligene relduparvovec Olenasufligene relduparvovec | - | - | - | [1] 19 19 💬
|
| 484 | Lysodase | - | - | - | - | [1] 19 19 💬
|
| 485 | Lysosomal acid lipase, Esterase cholesterol (human gene LIPA), Lysosomal acid lipase (human gene LIPA) | [1] Cholesterol Cholesterol | [1] Cholesterol
Cholesterol
💬
| - | - | [1] 19 19 💬
|
| 486 | Lysosomal acid lipase, Esterase, cholesterol (human gene LIPA), Lysosomal acid lipase (human gene LIPA) | [1] Cholesterol Cholesterol | [1] Cholesterol
Cholesterol
💬
| - | - | [1] 19 19 💬
|
| 487 | MABTHERA - 2 FIALE 100 MG 10 ML | - | - | - | - | [2] 19 19, 65 💬
|
| 488 | Magnetic Resonance Imaging | - | - | - | - | [10] 6 6, 13, 19, 22, 28, 34, 65, 205, 285, 299 💬
|
| 489 | Mechanical stimulation with Von Frey filaments | - | - | - | - | [1] 19 19 💬
|
| 490 | Medication to suppress the immune system | - | - | - | - | [1] 19 19 💬
|
| 491 | Melphalan | [1] Melphalan Melphalan | [2] Melphalan
Melphalan
,
Melphalan hydrochloride
💬
| - | - | [19] 11 11, 13, 14, 19, 20, 28, 34, 46, 60, 62, 65, 96, 107, 164, 222, 234, 284, 285, 299 💬
|
| 492 | Mepsevii | - | - | - | - | [1] 19 19 💬
|
| 493 | Mercaptamina | - | - | - | - | [1] 19 19 💬
|
| 494 | Mercaptamine | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [1] 19 19 💬
|
| 495 | MERCAPTAMINE BITARTRATE | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [1] 19 19 💬
|
| 496 | MERCAPTAMINE HYDROCHLORIDE | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [1] 19 19 💬
|
| 497 | Mercaptamine, mercamine, 2-aminoethanethiol | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [1] 19 19 💬
|
| 498 | Metazym | - | - | - | - | [1] 19 19 💬
|
| 499 | Methotrexate | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [41] 11 11, 13, 14, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 223, 240, 256, 270, 271, 284, 285, 286, 326, 331 💬
|
| 500 | Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [51] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
|
| 501 | MIGALASTAT | [1] Migalastat Migalastat | [2] Migalastat hydrochloride
Migalastat hydrochloride
,
Migalastat
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 502 | Migalastat HCl | [1] Migalastat Migalastat | [2] Migalastat hydrochloride
Migalastat hydrochloride
,
Migalastat
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 503 | Migalastat HCl 150 mg | [1] Migalastat Migalastat | [2] Migalastat hydrochloride
Migalastat hydrochloride
,
Migalastat
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 504 | Migalastat HCl 20 mg | [1] Migalastat Migalastat | [2] Migalastat hydrochloride
Migalastat hydrochloride
,
Migalastat
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 505 | MIGALASTAT HYDROCHLORIDE | [1] Migalastat Migalastat | [2] Migalastat hydrochloride
Migalastat hydrochloride
,
Migalastat
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 506 | Migalastat hydrocloride | [1] Migalastat Migalastat | [2] Migalastat hydrochloride
Migalastat hydrochloride
,
Migalastat
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 507 | MIGLUSTAT | [1] Miglustat Miglustat | [1] Miglustat
Miglustat
💬
| [1] UGCG UGCG 💬
| [2] Cornified envelope formation Cornified envelope formation, Sphingolipid metabolism 💬 | [3] 19 19, 256, 299 💬
|
| 508 | MIGLUSTAT (ZAVESCA) | [1] Miglustat Miglustat | [1] Miglustat
Miglustat
💬
| [1] UGCG UGCG 💬
| [2] Cornified envelope formation Cornified envelope formation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 509 | Montelukast | [1] Montelukast Montelukast | [2] Montelukast sodium
Montelukast sodium
,
Montelukast
💬
| [1] CYSLTR1 CYSLTR1 💬
| [2] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | [10] 6 6, 13, 19, 46, 61, 63, 85, 98, 222, 228 💬
|
| 510 | Moss-aGal (recombinant human alpha-galactosidase A produced in moss) | - | - | - | - | [1] 19 19 💬
|
| 511 | MOZOBIL - 20 MG/ML - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - F | - | - | - | - | [1] 19 19 💬
|
| 512 | MRI with contrast agent injection | - | - | - | - | [1] 19 19 💬
|
| 513 | MRI without contrast agent injection | - | - | - | - | [1] 19 19 💬
|
| 514 | Mucoangin | - | - | - | - | [1] 19 19 💬
|
| 515 | Mycophenolate mofetil | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [4] Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
,
Mycophenolate sodium
,
Mycophenolic acid
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [38] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 57, 60, 61, 62, 63, 65, 66, 93, 95, 96, 118, 162, 164, 222, 223, 224, 226, 234, 283, 284, 285, 300 💬
|
| 516 | Mycophenylate mofetil | - | - | - | - | [4] 19 19, 20, 222, 223 💬
|
| 517 | MYELOSTIM - 34 1 FLACONCINO LIOFILIZZATO 33.6 MIU + SIRINGA PRERIEMPITA SOLVENTE 1 ML | - | - | - | - | [2] 19 19, 65 💬
|
| 518 | N acetyl cysteine | [1] Cysteine Cysteine | [2] L-Cysteine
L-Cysteine
,
Cysteine hydrochloride
💬
| - | - | [2] 6 6, 19 💬
|
| 519 | N Acetyl L Leucine | [1] Leucine Leucine | [1] Leucine
Leucine
💬
| - | - | [1] 19 19 💬
|
| 520 | N-Acetyl-L Leucine | [1] Leucine Leucine | [1] Leucine
Leucine
💬
| - | - | [1] 19 19 💬
|
| 521 | N-Acetyl-L-Leucine | [1] Leucine Leucine | [1] Leucine
Leucine
💬
| - | - | [3] 18 18, 19, 65 💬
|
| 522 | N-Acetylcysteine | [1] Acetylcysteine Acetylcysteine | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [14] 6 6, 13, 19, 20, 21, 49, 58, 85, 90, 111, 164, 296, 299, 337 💬
|
| 523 | N-Acetylcysteine Amide | [2] Acetylcysteine Acetylcysteine, Acetylcysteine amide | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [3] 19 19, 90, 303 💬
|
| 524 | N-acetylgalactosamine 4-sulfatase | - | - | - | - | [1] 19 19 💬
|
| 525 | Naglazyme | - | - | - | - | [1] 19 19 💬
|
| 526 | Naglazyme (galsulfase) | [1] Galsulfase Galsulfase | [1] Galsulfase
Galsulfase
💬
| [1] ARSB ARSB 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 527 | Naglazyme® | - | - | - | - | [1] 19 19 💬
|
| 528 | NGN-101 | [1] NGN-101 NGN-101 | - | - | - | [1] 19 19 💬
|
| 529 | Nizubaglustat | [1] Nizubaglustat Nizubaglustat | [1] Nizubaglustat
Nizubaglustat
💬
| [2] GBA2 GBA2, UGCG 💬
| [3] Cornified envelope formation Cornified envelope formation, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 530 | Non applicable | - | - | - | - | [2] 10 10, 19 💬
|
| 531 | Odiparcil | [1] Odiparcil Odiparcil | - | - | - | [1] 19 19 💬
|
| 532 | OGT 918 | - | - | - | - | [2] 19 19, 299 💬
|
| 533 | OGT918 | - | - | - | - | [1] 19 19 💬
|
| 534 | OGT923 | - | - | - | - | [1] 19 19 💬
|
| 535 | OLENASUFLIGENE RELDUPARVOVEC | [1] Olenasufligene relduparvovec Olenasufligene relduparvovec | - | - | - | [1] 19 19 💬
|
| 536 | OLIPUDASE ALFA | [1] Olipudase alfa Olipudase alfa | [1] Olipudase alfa
Olipudase alfa
💬
| [1] SMPD1 SMPD1 💬
| [4] Lysosome biogenesis Lysosome biogenesis, Necroptosis, Sphingolipid metabolism, Sphingolipid signaling pathway 💬 | [1] 19 19 💬
|
| 537 | Olipudase alfa (GZ402665) | [1] Olipudase alfa Olipudase alfa | [1] Olipudase alfa
Olipudase alfa
💬
| [1] SMPD1 SMPD1 💬
| [4] Lysosome biogenesis Lysosome biogenesis, Necroptosis, Sphingolipid metabolism, Sphingolipid signaling pathway 💬 | [1] 19 19 💬
|
| 538 | Olipudase alfa (rhASM) | [1] Olipudase alfa Olipudase alfa | [1] Olipudase alfa
Olipudase alfa
💬
| [1] SMPD1 SMPD1 💬
| [4] Lysosome biogenesis Lysosome biogenesis, Necroptosis, Sphingolipid metabolism, Sphingolipid signaling pathway 💬 | [1] 19 19 💬
|
| 539 | OMNIPAQUE | - | - | - | - | [2] 19 19, 222 💬
|
| 540 | Ophthalmology exam | - | - | - | - | [1] 19 19 💬
|
| 541 | Optimized Prophylactic IM Therapy | - | - | - | - | [1] 19 19 💬
|
| 542 | Oral migalastat HCl | [1] Migalastat Migalastat | [2] Migalastat hydrochloride
Migalastat hydrochloride
,
Migalastat
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 543 | OSOME | - | - | - | - | [1] 19 19 💬
|
| 544 | Osteopetrosis Haploidentical Only Preparative Regimen | - | - | - | - | [5] 19 19, 20, 125, 234, 326 💬
|
| 545 | Osteopetrosis Only Preparative Regimen | - | - | - | - | [5] 19 19, 20, 125, 234, 326 💬
|
| 546 | Other: Blood sampling | - | - | - | - | [14] 6 6, 13, 19, 46, 49, 51, 53, 58, 67, 127, 222, 266, 296, 299 💬
|
| 547 | Other: Blood test | - | - | - | - | [11] 10 10, 19, 46, 51, 57, 65, 66, 83, 86, 96, 113 💬
|
| 548 | Other: Bone marrow and blood sampling | - | - | - | - | [1] 19 19 💬
|
| 549 | Other: Brief Pain Inventory questionnaire | - | - | - | - | [1] 19 19 💬
|
| 550 | Other: Challenge agent: capsaicin | [1] Capsaicin Capsaicin | [1] Capsaicin
Capsaicin
💬
| [1] TRPV1 TRPV1 💬
| [2] Inflammatory mediator regulation of TRP channels Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1] 19 19 💬
|
| 551 | Other: Control | - | - | - | - | [12] 6 6, 19, 67, 70, 75, 85, 96, 97, 162, 193, 226, 296 💬
|
| 552 | Other: Cysteamine bitartrate | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [1] 19 19 💬
|
| 553 | Other: Dried blood spot test | - | - | - | - | [1] 19 19 💬
|
| 554 | Other: Dried blood spot test for MPS | - | - | - | - | [1] 19 19 💬
|
| 555 | Other: Electroencephalogram (EEG) awake and extended overnight | - | - | - | - | [1] 19 19 💬
|
| 556 | Other: extraction of blood samples | - | - | - | - | [1] 19 19 💬
|
| 557 | Other: Fluorescein angiography | [1] Fluorescein Fluorescein | [2] Fluorescein
Fluorescein
,
Fluorescein sodium
💬
| - | - | [1] 19 19 💬
|
| 558 | Other: General and Neurological examination | - | - | - | - | [1] 19 19 💬
|
| 559 | Other: Ketogenic Diet | - | - | - | - | [2] 19 19, 67 💬
|
| 560 | Other: micromethod from samples taken from blood spots on filter paper | - | - | - | - | [1] 19 19 💬
|
| 561 | Other: Neurology exam | - | - | - | - | [1] 19 19 💬
|
| 562 | Other: No Investigational Product | - | - | - | - | [1] 19 19 💬
|
| 563 | Other: No IT treatment | - | - | - | - | [1] 19 19 💬
|
| 564 | Other: Palliative Care | - | - | - | - | [6] 19 19, 65, 121, 160, 308, 326 💬
|
| 565 | Other: Potable water | [1] Water Water | [1] Water
Water
💬
| - | - | [1] 19 19 💬
|
| 566 | Other: Quality of Life questionnaire | - | - | - | - | [1] 19 19 💬
|
| 567 | Other: Sample blood and 2D-echocardiography with Doppler | - | - | - | - | [2] 19 19, 58 💬
|
| 568 | Other: Vital signs | - | - | - | - | [1] 19 19 💬
|
| 569 | OTL-200 | - | - | - | - | [1] 19 19 💬
|
| 570 | OTL-200 Dispersion for Infusion | - | - | - | - | [1] 19 19 💬
|
| 571 | OTL-203 | [1] OTL-203 OTL-203 | - | - | - | [1] 19 19 💬
|
| 572 | Oxygen | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [30] 6 6, 13, 15, 19, 22, 36, 46, 49, 70, 71, 85, 86, 88, 90, 96, 97, 129, 149, 168, 193, 211, 226, 230, 235, 269, 271, 294, 298, 299, 330 💬
|
| 573 | Oxygen flow at the optic nerve head measurement | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [1] 19 19 💬
|
| 574 | Pabinafusp alfa | [1] Pabinafusp alfa Pabinafusp alfa | [1] Pabinafusp alfa
Pabinafusp alfa
💬
| [2] IDS IDS, TFRC 💬
| [8] Endocytosis Endocytosis, Ferroptosis, Glycosaminoglycan degradation, HIF-1 signaling pathway, Hematopoietic cell lineage, Lysosome biogenesis, TGF-beta signaling pathway, Virion - Lassa virus and SFTS virus 💬 | [1] 19 19 💬
|
| 575 | PARACETAMOLO | - | - | - | - | [10] 2 2, 11, 14, 19, 28, 53, 61, 63, 300, 309 💬
|
| 576 | PARACETAMOLO DOC GENERICI - 1000 MG COMPRESSA 16 COMPRESSE | - | - | - | - | [1] 19 19 💬
|
| 577 | Paricalcitol | [1] Paricalcitol Paricalcitol | [1] Paricalcitol
Paricalcitol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [5] 19 19, 66, 218, 238, 298 💬
|
| 578 | PBGM01 | [1] PBGM01 PBGM01 | - | - | - | [1] 19 19 💬
|
| 579 | PBKR03 | [1] PBKR03 PBKR03 | - | - | - | [1] 19 19 💬
|
| 580 | PEGUNIGALSIDASE ALFA | [1] Pegunigalsidase alfa Pegunigalsidase alfa | [1] Pegunigalsidase alfa
Pegunigalsidase alfa
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 581 | Pegunigalsidase alpha | - | - | - | - | [1] 19 19 💬
|
| 582 | Pegunigalsidase-alfa | - | - | - | - | [1] 19 19 💬
|
| 583 | Pending | - | - | - | - | [7] 6 6, 13, 19, 96, 97, 113, 302 💬
|
| 584 | Pentosan Polysulfat SP 54® injection solution | - | - | - | - | [1] 19 19 💬
|
| 585 | Pentosan polysulfate | [1] Pentosan polysulfate Pentosan polysulfate | [1] Pentosan polysulfate sodium
Pentosan polysulfate sodium
💬
| - | - | [3] 19 19, 26, 226 💬
|
| 586 | PENTOSAN POLYSULFATE SODIUM | [1] Pentosan polysulfate Pentosan polysulfate | [1] Pentosan polysulfate sodium
Pentosan polysulfate sodium
💬
| - | - | [1] 19 19 💬
|
| 587 | Pentosan Polysulphate SP54 | [1] Pentosan polysulfate Pentosan polysulfate | [1] Pentosan polysulfate sodium
Pentosan polysulfate sodium
💬
| - | - | [1] 19 19 💬
|
| 588 | Pentosan Polysulphate SP54® | [1] Pentosan polysulfate Pentosan polysulfate | [1] Pentosan polysulfate sodium
Pentosan polysulfate sodium
💬
| - | - | [1] 19 19 💬
|
| 589 | Perdix | - | - | - | - | [1] 19 19 💬
|
| 590 | Plant cell expressed recombinant glucocerebrosidase (prGCD) | - | - | - | - | [1] 19 19 💬
|
| 591 | Plant Cell Recombinant Glucocerebrosidase | - | - | - | - | [1] 19 19 💬
|
| 592 | PLX-200 | - | - | - | - | [1] 19 19 💬
|
| 593 | Prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [58] 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
|
| 594 | PREDNISONE DOC GENERICI - 5 MG COMPRESSE 10 COMPRESSE IN BLISTER PVC-PVDC/ALU | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 19 19 💬
|
| 595 | Prevenar13 | - | - | - | - | [3] 19 19, 79, 265 💬
|
| 596 | PrGCD | [1] Taliglucerase alfa Taliglucerase alfa | [1] Taliglucerase alfa
Taliglucerase alfa
💬
| [1] GBA1 GBA1 💬
| [4] Cornified envelope formation Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 597 | PROCYSBI | - | - | - | - | [1] 19 19 💬
|
| 598 | Prophylactic Immunomodulatory (IM) Therapy | - | - | - | - | [1] 19 19 💬
|
| 599 | PRX-102 | - | - | - | - | [1] 19 19 💬
|
| 600 | PRX-102 (pegunigalsidase alfa) | [1] Pegunigalsidase alfa Pegunigalsidase alfa | [1] Pegunigalsidase alfa
Pegunigalsidase alfa
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 601 | PRX-102 1 mg/kg every 2 weeks | - | - | - | - | [1] 19 19 💬
|
| 602 | PRX-102 1 mg/kg every two weeks | - | - | - | - | [1] 19 19 💬
|
| 603 | PRX-102 2 mg/kg every 4 weeks | - | - | - | - | [1] 19 19 💬
|
| 604 | PRX-112 | - | - | - | - | [1] 19 19 💬
|
| 605 | PRX102 | - | - | - | - | [1] 19 19 💬
|
| 606 | PTC124 | - | - | - | - | [4] 19 19, 113, 246, 299 💬
|
| 607 | Purified form of the lysosomal enzyme iduronate-2-sulfatase | - | - | - | - | [1] 19 19 💬
|
| 608 | PYRIMETHAMINE | [1] Pyrimethamine Pyrimethamine | [1] Pyrimethamine
Pyrimethamine
💬
| - | - | [4] 2 2, 4, 19, 65 💬
|
| 609 | Quantitative chemical shift imaging (QCSI) | - | - | - | - | [1] 19 19 💬
|
| 610 | RAAV 2/6 hIDS DONOR | - | - | - | - | [1] 19 19 💬
|
| 611 | RAAV2/5-hNAGLU | - | - | - | - | [1] 19 19 💬
|
| 612 | RAAV2/6 Left ZFN Vector | - | - | - | - | [1] 19 19 💬
|
| 613 | RAAV2/6 Right ZFN Vector | - | - | - | - | [1] 19 19 💬
|
| 614 | RAAV9.CMV.hNAGLU | - | - | - | - | [1] 19 19 💬
|
| 615 | Radiation: Total Body Irradiation | - | - | - | - | [11] 19 19, 36, 49, 51, 60, 62, 65, 96, 222, 283, 284 💬
|
| 616 | Radiation: Total Body Irradiation with Marrow Boosting | - | - | - | - | [2] 19 19, 234 💬
|
| 617 | Rebisufligene etisparvovec | [1] Rebisufligene etisparvovec Rebisufligene etisparvovec | - | - | - | [1] 19 19 💬
|
| 618 | Recombinant Adeno-associated virus 2/6 vector encoding the cDNA for human alpha galactosidase A | - | - | - | - | [1] 19 19 💬
|
| 619 | Recombinant alpha-galactosidase A | - | - | - | - | [1] 19 19 💬
|
| 620 | Recombinant human acid sphingomyelinase | - | - | - | - | [1] 19 19 💬
|
| 621 | RECOMBINANT HUMAN ACID SPHINGOMYELINASE (rhASM) | - | - | - | - | [1] 19 19 💬
|
| 622 | Recombinant human alpha galactosidase A (agalsidase beta) | [1] Agalsidase beta Agalsidase beta | [1] Agalsidase beta
Agalsidase beta
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 623 | Recombinant human alpha-galactosidase | - | - | - | - | [1] 19 19 💬
|
| 624 | Recombinant human alpha-galactosidase A (agalsidase beta) | [1] Agalsidase beta Agalsidase beta | [1] Agalsidase beta
Agalsidase beta
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 625 | Recombinant human alpha-galactosidase abbreviated as r-h-alpha-GAL | - | - | - | - | [1] 19 19 💬
|
| 626 | Recombinant human alpha-mannosidase | - | - | - | - | [1] 19 19 💬
|
| 627 | Recombinant Human Alpha-N-Acetylglucosaminidase (rhNAGLU) | - | - | - | - | [1] 19 19 💬
|
| 628 | RECOMBINANT HUMAN ARYLSULFATASE A | [1] Recombinant human arylsulfatase A Recombinant human arylsulfatase A | - | - | - | [1] 19 19 💬
|
| 629 | Recombinant Human Arylsulfatase A (rhASA) | [1] Recombinant human arylsulfatase A Recombinant human arylsulfatase A | - | - | - | [1] 19 19 💬
|
| 630 | Recombinant Human Arylsulfatase A (rhASA, | [1] Recombinant human arylsulfatase A Recombinant human arylsulfatase A | - | - | - | [1] 19 19 💬
|
| 631 | Recombinant human Arysulfatase B, recombinant human N-acetylgalactosamine 4-sulfatase | - | - | - | - | [1] 19 19 💬
|
| 632 | RECOMBINANT HUMAN BETA GLUCURONIDASE | - | - | - | - | [1] 19 19 💬
|
| 633 | Recombinant human beta-glucuronidase | - | - | - | - | [1] 19 19 💬
|
| 634 | Recombinant human beta-glucuronidase (rhGUS) | - | - | - | - | [1] 19 19 💬
|
| 635 | Recombinant human betaglucuronidase | - | - | - | - | [1] 19 19 💬
|
| 636 | Recombinant human derived macrophage-targeted beta-Glucocerebrosidase | - | - | - | - | [1] 19 19 💬
|
| 637 | Recombinant human derived macrophage-targeted ß-Glucocerebrosidase | - | - | - | - | [1] 19 19 💬
|
| 638 | Recombinant human glucerebrosidase | - | - | - | - | [1] 19 19 💬
|
| 639 | Recombinant human glucocerebrosidase | - | - | - | - | [1] 19 19 💬
|
| 640 | Recombinant Human Glucocerebrosidase (prGCD) | [1] Taliglucerase alfa Taliglucerase alfa | [1] Taliglucerase alfa
Taliglucerase alfa
💬
| [1] GBA1 GBA1 💬
| [4] Cornified envelope formation Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 641 | Recombinant human heparan N-sulfatase | - | - | - | - | [1] 19 19 💬
|
| 642 | Recombinant human heparan N-sulfatase (rhHNS) | - | - | - | - | [1] 19 19 💬
|
| 643 | Recombinant human heparan N-sulfatase [rhHNS] | - | - | - | - | [1] 19 19 💬
|
| 644 | Recombinant human heparan Nsulfatase (rhHNS) | - | - | - | - | [1] 19 19 💬
|
| 645 | Recombinant human lysosomal acid lipase | - | - | - | - | [1] 19 19 💬
|
| 646 | Recombinant human lysosomal acid lipase (rhLAL) | - | - | - | - | [1] 19 19 💬
|
| 647 | Recombinant human lysosomal acid lipase (rhLAL), esterase, cholesterol (human gene LIPA) | [1] Cholesterol Cholesterol | [1] Cholesterol
Cholesterol
💬
| - | - | [1] 19 19 💬
|
| 648 | Recombinant human lysosomal acid lipase (rhLAL), esterase, cholesterol (human gene LIPA), lysosomal acid lipase (human gene LIPA) | [1] Cholesterol Cholesterol | [1] Cholesterol
Cholesterol
💬
| - | - | [1] 19 19 💬
|
| 649 | Recombinant human lysosomal alpha-mannosidase | - | - | - | - | [1] 19 19 💬
|
| 650 | Recombinant human N-acetylgalactosamine 4-sulfatase | - | - | - | - | [1] 19 19 💬
|
| 651 | Recombinant human N-acetylgalactosamine 6-sulfatase, BMN 110 | - | - | - | - | [1] 19 19 💬
|
| 652 | Recombinant human N-acetylgalactosamine 6-sulfatase, BMN 110 drug substance | - | - | - | - | [1] 19 19 💬
|
| 653 | Recombinant human N-acetylgalactosamine-6-sulfatase (rhGALNS) | - | - | - | - | [1] 19 19 💬
|
| 654 | Recombinant human N-acetylgalactosamine-6-sulfatase, BMN 110 | - | - | - | - | [1] 19 19 💬
|
| 655 | Recombinant human N-acetylgalactosamine-6-sulfatase, BMN 110 drug substance | - | - | - | - | [1] 19 19 💬
|
| 656 | Recombinant human Nacetylgalactosamine- | - | - | - | - | [1] 19 19 💬
|
| 657 | Recombinant human tripeptidyl peptidase-1 | [1] Cerliponase alfa Cerliponase alfa | [1] Cerliponase alfa
Cerliponase alfa
💬
| [1] TPP1 TPP1 💬
| [1] Lysosome biogenesis Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 658 | RECOMBINANT HUMAN TRIPEPTIDYL PEPTIDASE-1 (RHTPP1) | [1] Cerliponase alfa Cerliponase alfa | [1] Cerliponase alfa
Cerliponase alfa
💬
| [1] TPP1 TPP1 💬
| [1] Lysosome biogenesis Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 659 | Recombinant self-complementary adeno-associated viral vector serotype 9 containing the human CLN6 gene | - | - | - | - | [1] 19 19 💬
|
| 660 | Reduced Intensity Conditioning | - | - | - | - | [2] 19 19, 65 💬
|
| 661 | Reminder capsules | - | - | - | - | [1] 19 19 💬
|
| 662 | Reminder Product | - | - | - | - | [1] 19 19 💬
|
| 663 | REPLAGAL | - | - | - | - | [1] 19 19 💬
|
| 664 | Replagal (Agalsidase Alfa) | [1] Agalsidase alfa Agalsidase alfa | [1] Agalsidase alfa
Agalsidase alfa
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 665 | Replagal agalsidase alfa | [1] Agalsidase alfa Agalsidase alfa | [1] Agalsidase alfa
Agalsidase alfa
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 666 | REPLAGAL ® | - | - | - | - | [1] 19 19 💬
|
| 667 | RGX-111 | [1] RGX-111 RGX-111 | - | - | - | [1] 19 19 💬
|
| 668 | RGX-121 | [1] RGX-121 RGX-121 | - | - | - | [1] 19 19 💬
|
| 669 | Rh Growth Hormone | - | - | - | - | [1] 19 19 💬
|
| 670 | RhARSA | - | - | - | - | [1] 19 19 💬
|
| 671 | RhASA | - | - | - | - | [1] 19 19 💬
|
| 672 | RhASA - Dose Level 1 | - | - | - | - | [1] 19 19 💬
|
| 673 | RhASA - Dose Level 2 | - | - | - | - | [1] 19 19 💬
|
| 674 | RhASA - Dose Level 3 | - | - | - | - | [1] 19 19 💬
|
| 675 | RhASA [recombinant human arylsulfatase A], formerly HGT-1110, now also known as TAK-611 | [2] Recombinant human arylsulfatase A Recombinant human arylsulfatase A, TAK-611 | - | - | - | [1] 19 19 💬
|
| 676 | RhASM | - | - | - | - | [1] 19 19 💬
|
| 677 | RHGUS | - | - | - | - | [1] 19 19 💬
|
| 678 | RhHNS-10 mg | - | - | - | - | [1] 19 19 💬
|
| 679 | RhHNS-45 mg | - | - | - | - | [1] 19 19 💬
|
| 680 | RhHNS-90 mg | - | - | - | - | [1] 19 19 💬
|
| 681 | RhIDU (recombinant human-Alpha-L-Iduronidase) | - | - | - | - | [1] 19 19 💬
|
| 682 | RhLAMAN | [1] Velmanase alfa Velmanase alfa | [1] Velmanase alfa
Velmanase alfa
💬
| [1] MAN2B1 MAN2B1 💬
| [2] Lysosome biogenesis Lysosome biogenesis, Other glycan degradation 💬 | [1] 19 19 💬
|
| 683 | RhNAGLU | - | - | - | - | [1] 19 19 💬
|
| 684 | RhNAGLU radiolabelled | - | - | - | - | [1] 19 19 💬
|
| 685 | RHNAGLU-IGF2 | [1] Tralesinidase alfa Tralesinidase alfa | [1] Tralesinidase alfa
Tralesinidase alfa
💬
| [2] IGF2 IGF2, NAGLU 💬
| [9] Glycosaminoglycan degradation Glycosaminoglycan degradation, Hepatocellular carcinoma, Hormone signaling, Lysosome biogenesis, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Ras signaling pathway 💬 | [1] 19 19 💬
|
| 686 | Rimiducid | [1] Rimiducid Rimiducid | [1] Rimiducid
Rimiducid
💬
| [1] CASP9 CASP9 💬
| [34] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Colorectal cancer, Endometrial cancer, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Huntington disease, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Measles, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parkinson disease, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Prostate cancer, Small cell lung cancer, Thyroid hormone signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Viral myocarditis, p53 signaling pathway 💬 | [7] 19 19, 49, 60, 65, 284, 285, 326 💬
|
| 687 | RITUXIMAB | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [54] 11 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
| 688 | Rivogenlecleucel | [1] Rivogenlecleucel Rivogenlecleucel | [1] Rivogenlecleucel
Rivogenlecleucel
💬
| - | - | [6] 19 19, 60, 65, 284, 285, 326 💬
|
| 689 | RP 103 | - | - | - | - | [2] 8 8, 19 💬
|
| 690 | RP103 | - | - | - | - | [2] 8 8, 19 💬
|
| 691 | RVX000222 | - | - | - | - | [1] 19 19 💬
|
| 692 | SAF-301 | - | - | - | - | [1] 19 19 💬
|
| 693 | Saline Solution for Injection | - | - | - | - | [1] 19 19 💬
|
| 694 | SAR402671, GZ402671 or GZ / SAR402671 | - | - | - | - | [1] 19 19 💬
|
| 695 | SAR402671, GZ402671 or GZ/SAR402671 | - | - | - | - | [3] 6 6, 19, 67 💬
|
| 696 | SB-318 | - | - | - | - | [1] 19 19 💬
|
| 697 | SB-47171 | - | - | - | - | [1] 19 19 💬
|
| 698 | SB-47898 | - | - | - | - | [1] 19 19 💬
|
| 699 | SB-913 | - | - | - | - | [1] 19 19 💬
|
| 700 | SB-A6P-HRL Donor Vector | - | - | - | - | [1] 19 19 💬
|
| 701 | SB-FIX | - | - | - | - | [1] 19 19 💬
|
| 702 | SB-IDUA | - | - | - | - | [1] 19 19 💬
|
| 703 | SBC-102 | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬
| [1] LIPA LIPA 💬
| [4] Cholesterol metabolism Cholesterol metabolism, Efferocytosis, Lysosome biogenesis, Steroid biosynthesis 💬 | [1] 19 19 💬
|
| 704 | SBC-102, recombinant human lysosomal acid lipase | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬
| [1] LIPA LIPA 💬
| [4] Cholesterol metabolism Cholesterol metabolism, Efferocytosis, Lysosome biogenesis, Steroid biosynthesis 💬 | [1] 19 19 💬
|
| 705 | SBC-103 | - | - | - | - | [1] 19 19 💬
|
| 706 | ScAAV9.CB.CLN6 | - | - | - | - | [1] 19 19 💬
|
| 707 | ScAAV9.CB.CLN6 (dose: 1.5E14 vector genomes) | - | - | - | - | [1] 19 19 💬
|
| 708 | ScAAV9.U1A.hSGSH | [1] Rebisufligene etisparvovec Rebisufligene etisparvovec | - | - | - | [1] 19 19 💬
|
| 709 | ScAAV9.U1A.SGSH | - | - | - | - | [1] 19 19 💬
|
| 710 | Sebelipasa Alfa | - | - | - | - | [1] 19 19 💬
|
| 711 | Sebelipase Alfa | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬
| [1] LIPA LIPA 💬
| [4] Cholesterol metabolism Cholesterol metabolism, Efferocytosis, Lysosome biogenesis, Steroid biosynthesis 💬 | [1] 19 19 💬
|
| 712 | Sebelipase alfa (SBC-102) | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬
| [1] LIPA LIPA 💬
| [4] Cholesterol metabolism Cholesterol metabolism, Efferocytosis, Lysosome biogenesis, Steroid biosynthesis 💬 | [1] 19 19 💬
|
| 713 | Sebelipase alfa 0.35 mg/kg | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬
| [1] LIPA LIPA 💬
| [4] Cholesterol metabolism Cholesterol metabolism, Efferocytosis, Lysosome biogenesis, Steroid biosynthesis 💬 | [1] 19 19 💬
|
| 714 | Sebelipase alfa 1 mg/kg | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬
| [1] LIPA LIPA 💬
| [4] Cholesterol metabolism Cholesterol metabolism, Efferocytosis, Lysosome biogenesis, Steroid biosynthesis 💬 | [1] 19 19 💬
|
| 715 | Sebelipase alfa 3 mg/kg | [1] Sebelipase alfa Sebelipase alfa | [1] Sebelipase alfa
Sebelipase alfa
💬
| [1] LIPA LIPA 💬
| [4] Cholesterol metabolism Cholesterol metabolism, Efferocytosis, Lysosome biogenesis, Steroid biosynthesis 💬 | [1] 19 19 💬
|
| 716 | SHP611 | - | - | - | - | [1] 19 19 💬
|
| 717 | SHP675 | - | - | - | - | [1] 19 19 💬
|
| 718 | Sirolimus | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [46] 6 6, 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
|
| 719 | Skeletal survey | - | - | - | - | [1] 19 19 💬
|
| 720 | Skin biopsy | - | - | - | - | [6] 6 6, 19, 21, 51, 84, 86 💬
|
| 721 | Slit Lamp assessment and intra-ocular pressure measurement | - | - | - | - | [1] 19 19 💬
|
| 722 | SOBI003 | - | - | - | - | [1] 19 19 💬
|
| 723 | Sofosbuvir | [1] Sofosbuvir Sofosbuvir | [1] Sofosbuvir
Sofosbuvir
💬
| - | - | [1] 19 19 💬
|
| 724 | Somatropin (DNA origin) | - | - | - | - | [1] 19 19 💬
|
| 725 | Speech and modified barium swallow study | [1] Barium Barium | - | - | - | [1] 19 19 💬
|
| 726 | Ss-mercaptoethylamine Hydrochloride & 2-aminoethanethiol Hydrochloride | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [1] 19 19 💬
|
| 727 | ST-920 | - | - | - | - | [1] 19 19 💬
|
| 728 | Stem Cell Transplant | - | - | - | - | [6] 19 19, 20, 60, 65, 164, 284 💬
|
| 729 | Stem Cell Transplantation | - | - | - | - | [14] 13 13, 19, 20, 46, 48, 51, 60, 62, 65, 90, 125, 164, 234, 326 💬
|
| 730 | SUB195712 | - | - | - | - | [1] 19 19 💬
|
| 731 | Surgery to implant human CNS stem cells (HuCNS-SC) | - | - | - | - | [1] 19 19 💬
|
| 732 | TAK-611 | [1] TAK-611 TAK-611 | - | - | - | [1] 19 19 💬
|
| 733 | TAK-675 | - | - | - | - | [1] 19 19 💬
|
| 734 | TALIGLUCERASE ALFA | [1] Taliglucerase alfa Taliglucerase alfa | [1] Taliglucerase alfa
Taliglucerase alfa
💬
| [1] GBA1 GBA1 💬
| [4] Cornified envelope formation Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 735 | Taliglucerase alfa - Recombinant human glucocerebrosidase | [1] Taliglucerase alfa Taliglucerase alfa | [1] Taliglucerase alfa
Taliglucerase alfa
💬
| [1] GBA1 GBA1 💬
| [4] Cornified envelope formation Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 736 | TBD | - | - | - | - | [5] 19 19, 86, 90, 276, 299 💬
|
| 737 | Temperature sensitivity measurement with Advanced Thermal Stimulation | - | - | - | - | [1] 19 19 💬
|
| 738 | Thiotepa | [1] Thiotepa Thiotepa | [1] Thiotepa
Thiotepa
💬
| - | - | [14] 13 13, 19, 20, 28, 46, 51, 60, 65, 85, 96, 107, 164, 284, 285 💬
|
| 739 | Thiotepa--escalated dose | [1] Thiotepa Thiotepa | [1] Thiotepa
Thiotepa
💬
| - | - | [4] 19 19, 20, 65, 284 💬
|
| 740 | Thiotepa--single daily dose | [1] Thiotepa Thiotepa | [1] Thiotepa
Thiotepa
💬
| - | - | [4] 19 19, 20, 65, 284 💬
|
| 741 | Tividenofusp alfa | [1] Tividenofusp alfa Tividenofusp alfa | [1] Tividenofusp alfa
Tividenofusp alfa
💬
| [2] IDS IDS, TFRC 💬
| [8] Endocytosis Endocytosis, Ferroptosis, Glycosaminoglycan degradation, HIF-1 signaling pathway, Hematopoietic cell lineage, Lysosome biogenesis, TGF-beta signaling pathway, Virion - Lassa virus and SFTS virus 💬 | [1] 19 19 💬
|
| 742 | Total body Irradiation | - | - | - | - | [6] 19 19, 20, 51, 60, 65, 285 💬
|
| 743 | Tralesinidase alfa | [1] Tralesinidase alfa Tralesinidase alfa | [1] Tralesinidase alfa
Tralesinidase alfa
💬
| [2] IGF2 IGF2, NAGLU 💬
| [9] Glycosaminoglycan degradation Glycosaminoglycan degradation, Hepatocellular carcinoma, Hormone signaling, Lysosome biogenesis, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Ras signaling pathway 💬 | [1] 19 19 💬
|
| 744 | Tralesinidase alfa (TA) | [1] Tralesinidase alfa Tralesinidase alfa | [1] Tralesinidase alfa
Tralesinidase alfa
💬
| [2] IGF2 IGF2, NAGLU 💬
| [9] Glycosaminoglycan degradation Glycosaminoglycan degradation, Hepatocellular carcinoma, Hormone signaling, Lysosome biogenesis, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Ras signaling pathway 💬 | [1] 19 19 💬
|
| 745 | Trappsol Cyclo | - | - | - | - | [1] 19 19 💬
|
| 746 | TREOSULFAN | [1] Treosulfan Treosulfan | [1] Treosulfan
Treosulfan
💬
| - | - | [6] 13 13, 19, 62, 65, 284, 286 💬
|
| 747 | Triapin | - | - | - | - | [1] 19 19 💬
|
| 748 | Triapin& triapin Mite | - | - | - | - | [1] 19 19 💬
|
| 749 | Tropicamide | [1] Tropicamide Tropicamide | [1] Tropicamide
Tropicamide
💬
| [5] CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬
| [14] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | [2] 6 6, 19 💬
|
| 750 | TSHA-101 | [1] TSHA-101 TSHA-101 | - | - | - | [1] 19 19 💬
|
| 751 | Unrelated Umbilical Cord Blood Transplant | - | - | - | - | [1] 19 19 💬
|
| 752 | UPLYSO | - | - | - | - | [1] 19 19 💬
|
| 753 | Urine collection | - | - | - | - | [1] 19 19 💬
|
| 754 | USAN: sebelipasa alfa | - | - | - | - | [1] 19 19 💬
|
| 755 | USAN: sebelipase alpha | - | - | - | - | [1] 19 19 💬
|
| 756 | UX003 | - | - | - | - | [1] 19 19 💬
|
| 757 | UX111 | - | - | - | - | [1] 19 19 💬
|
| 758 | Vector viral adenoasociado de serotipo 9 que contiene el gen de la sulfamidasa humana | - | - | - | - | [1] 19 19 💬
|
| 759 | VELAGLUCERASE ALFA | [1] Velaglucerase alfa Velaglucerase alfa | [1] Velaglucerase alfa
Velaglucerase alfa
💬
| [1] GBA1 GBA1 💬
| [4] Cornified envelope formation Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 760 | Velaglucerasi alfa | - | - | - | - | [1] 19 19 💬
|
| 761 | VELMANASE ALFA | [1] Velmanase alfa Velmanase alfa | [1] Velmanase alfa
Velmanase alfa
💬
| [1] MAN2B1 MAN2B1 💬
| [2] Lysosome biogenesis Lysosome biogenesis, Other glycan degradation 💬 | [1] 19 19 💬
|
| 762 | Velmanase Alfa (e.g. Lamazym) | [1] Velmanase alfa Velmanase alfa | [1] Velmanase alfa
Velmanase alfa
💬
| [1] MAN2B1 MAN2B1 💬
| [2] Lysosome biogenesis Lysosome biogenesis, Other glycan degradation 💬 | [1] 19 19 💬
|
| 763 | Venglustat | [1] Venglustat Venglustat | [2] Venglustat
Venglustat
,
Venglustat malate
💬
| [1] UGCG UGCG 💬
| [2] Cornified envelope formation Cornified envelope formation, Sphingolipid metabolism 💬 | [3] 6 6, 19, 67 💬
|
| 764 | Venglustat (GZ402671) | [1] Venglustat Venglustat | [2] Venglustat
Venglustat
,
Venglustat malate
💬
| [1] UGCG UGCG 💬
| [2] Cornified envelope formation Cornified envelope formation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 765 | Venglustat GZ402671 | [1] Venglustat Venglustat | [2] Venglustat
Venglustat
,
Venglustat malate
💬
| [1] UGCG UGCG 💬
| [2] Cornified envelope formation Cornified envelope formation, Sphingolipid metabolism 💬 | [2] 19 19, 67 💬
|
| 766 | Venglustat L-malate | [1] Venglustat Venglustat | [2] Venglustat
Venglustat
,
Venglustat malate
💬
| [1] UGCG UGCG 💬
| [2] Cornified envelope formation Cornified envelope formation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 767 | Venglustat malate | [1] Venglustat Venglustat | [2] Venglustat
Venglustat
,
Venglustat malate
💬
| [1] UGCG UGCG 💬
| [2] Cornified envelope formation Cornified envelope formation, Sphingolipid metabolism 💬 | [3] 6 6, 19, 67 💬
|
| 768 | Venglustat malato | [1] Venglustat Venglustat | [2] Venglustat
Venglustat
,
Venglustat malate
💬
| [1] UGCG UGCG 💬
| [2] Cornified envelope formation Cornified envelope formation, Sphingolipid metabolism 💬 | [2] 19 19, 67 💬
|
| 769 | VenglustatProduct Code: SAR402671, GZ402671 or GZ / SAR402671Pharmaceutical Form: TabletINN or Proposed INN: Venglustat malateCAS Number: 1629063-78-0Current Sponsor code: GZ402671Other descriptive name: GZ/SAR402671Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 6-Pharmaceutical form of the placebo: TabletRoute of administration of the placebo: Oral useProduct Name: venglustatProduct Code: SAR402671, GZ402671 or GZ / SAR402671Pharmaceutical Form: TabletINN or Proposed INN: Venglustat malateCAS Number: 1629063-78-0Current Sponsor code: GZ402671Other descriptive name: GZ/SAR402671Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 15-Pharmaceutical form of the placebo: TabletRoute of administration of the placebo: Oral use | [1] Venglustat Venglustat | [2] Venglustat
Venglustat
,
Venglustat malate
💬
| [1] UGCG UGCG 💬
| [2] Cornified envelope formation Cornified envelope formation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 770 | Verenafusp alfa 12 mg/kg | - | - | - | - | [1] 19 19 💬
|
| 771 | Verenafusp alfa 6 mg/kg | - | - | - | - | [1] 19 19 💬
|
| 772 | Verenafusp alfa 9 mg/kg | - | - | - | - | [1] 19 19 💬
|
| 773 | Vestronidase alfa | [1] Vestronidase alfa Vestronidase alfa | [1] Vestronidase alfa
Vestronidase alfa
💬
| [1] GUSB GUSB 💬
| [6] Ascorbate and aldarate metabolism Ascorbate and aldarate metabolism, Drug metabolism - other enzymes, Glycosaminoglycan degradation, Lysosome biogenesis, Pentose and glucuronate interconversions, Porphyrin metabolism 💬 | [1] 19 19 💬
|
| 774 | VGN-R08b | - | - | - | - | [1] 19 19 💬
|
| 775 | Vimizim® (elosulfase alfa) | [1] Elosulfase alfa Elosulfase alfa | [1] Elosulfase alfa
Elosulfase alfa
💬
| [1] GALNS GALNS 💬
| [2] Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 776 | Visual field testing | - | - | - | - | [1] 19 19 💬
|
| 777 | Vitamin D | [1] Vitamin D Vitamin D | - | - | - | [26] 3 3, 6, 13, 15, 19, 41, 43, 44, 46, 49, 50, 68, 74, 93, 95, 96, 97, 98, 179, 222, 228, 235, 256, 274, 298, 299 💬
|
| 778 | Vitamin E | [1] Vitamin E Vitamin E | [1] Vitamin E
Vitamin E
💬
| - | - | [12] 2 2, 6, 13, 19, 20, 46, 90, 96, 97, 206, 299, 317 💬
|
| 779 | Vosoritide | [1] Vosoritide Vosoritide | [1] Vosoritide
Vosoritide
💬
| [1] NPR2 NPR2 💬
| [5] Hormone signaling Hormone signaling, Oxytocin signaling pathway, Purine metabolism, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [3] 19 19, 195, 276 💬
|
| 780 | Vosoritide Injection [Voxzogo] | [1] Vosoritide Vosoritide | [1] Vosoritide
Vosoritide
💬
| [1] NPR2 NPR2 💬
| [5] Hormone signaling Hormone signaling, Oxytocin signaling pathway, Purine metabolism, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 19 19, 276 💬
|
| 781 | VPRIV | - | - | - | - | [1] 19 19 💬
|
| 782 | VPRIV - 400 U - POLVERE PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO(VETRO) 1 FLACONCINO | - | - | - | - | [1] 19 19 💬
|
| 783 | VPRIV 400 Units powder for solution of infusion | - | - | - | - | [1] 19 19 💬
|
| 784 | VPRIV ®, | - | - | - | - | [1] 19 19 💬
|
| 785 | VPRIV® | - | - | - | - | [1] 19 19 💬
|
| 786 | VTS-270 | - | - | - | - | [1] 19 19 💬
|
| 787 | Warfarin | [1] Warfarin Warfarin | [3] Warfarin sodium
Warfarin sodium
,
Warfarin potassium
,
Warfarin
💬
| [2] NQO1 NQO1, VKORC1 💬
| [5] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [15] 6 6, 8, 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬
|
| 788 | Water | [1] Water Water | [1] Water
Water
💬
| - | - | [36] 2 2, 3, 5, 6, 13, 17, 19, 22, 35, 46, 49, 51, 53, 56, 57, 62, 63, 64, 65, 66, 67, 70, 72, 85, 86, 96, 97, 206, 215, 225, 226, 230, 240, 274, 278, 299 💬
|
| 789 | Whole body Protein turnover | - | - | - | - | [4] 19 19, 46, 96, 299 💬
|
| 790 | ZAVESCA | - | - | - | - | [3] 19 19, 256, 299 💬
|
| 791 | Zavesca (Miglustat) | [1] Miglustat Miglustat | [1] Miglustat
Miglustat
💬
| [1] UGCG UGCG 💬
| [2] Cornified envelope formation Cornified envelope formation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 792 | ZAVESCA 84CPS 100MG | - | - | - | - | [1] 19 19 💬
|
| 793 | Zestoretic 10,20 | - | - | - | - | [1] 19 19 💬
|
| 794 | ZESTORIC | - | - | - | - | [1] 19 19 💬
|
| 795 | Zestril | - | - | - | - | [3] 19 19, 67, 222 💬
|